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BIOGRAPHY OF AUTHORS
The first author, Dr. Ahmad Z. Qureshi is a physical medicine and rehabilitation specialist with sub specializations in 
neurorehabilitation and interventional rehabilitation. He has a unique experience of obtaining his specialty and 
subspecialty training in three different regions of the globe, including Pakistan, Kingdom of Saudi Arabia and the United 
States. Dr. Qureshi, with help of Dr. Jenkins, has narrated his perspective on rehabilitation of neurological disabilities in 
three entirely different rehabilitation setups around the globe.
ABSTRACT
The authors have narrated their perspective on rehabilitation of neurological disabilities based upon their experiences in 
three different regions of the globe, hence the word "three dimensional". It also reflects the need of holistic approach in 
neurorehabilitation. The article emphasizes the significance of impact of socio-cultural factors on disability and the way 
different challenges can change outcomes of the same neurological impairment in different health care systems. The 
understanding, perception and management of disability secondary to any neurological impairment varies greatly from 
one region to another across the world. Hence treatment guidelines applicable in one socioeconomic setup may not be 
applicable in another setting, making neurorehabilitation a very unique specialty of medicine. Conventionally, in the field 
of medicine, popular treatment guidelines usually originate in high income countries, which are considered standards of 
practice even by developing health systems regardless of the feasibility of their application. Neurorehabilitation guidelines 
need to be unique to health systems having socio-economic and cultural similarities. The general perception of disability 
and cultural needs should be given high consideration while dealing with neurological impairments; rendering the need of 
tailored guidelines specific to each population. This idea is new to medical education and disability care. It deserves more 
attention among health care providers dealing with functional limitations secondary to neurological impairments. 
The term three-dimensional, or 3-D, usually refers to an 
object’s existing along three different axes that intersect 
at specific angles.  The three axes, or dimensions, 
represent height, width and depth and determine the 
orientation and direction of an object in space.  Increasing 
the number of dimensions of an object from one or two to 
three greatly increases our perception and understanding 
of the object.  This even impacts our perception of 
characteristics of the object, such as color, that we may 
not suspect were related.1 Consider, then, the possibility 
of extending this “holistic” model to the rehabilitation 
process of patients with neurological disabilities. Could 
impairment categories such as stroke, brain injury or 
spinal cord injury be considered three dimensional? Yes, 
we might actually view and more fully understand any 
neurological impairment by exploring its multiple 
dimensions in different health systems around the globe. 
Recently, disability issues have taken on an increasingly 
prominent role on international stages.2 I started off my 
externship in Physical Medicine and Rehabilitation at 
Mayo Hospital Lahore Pakistan and joined the same 
department as a resident trainee. After spending a total of 
9 months there I was selected to continue to my 
residency training at King Fahad Medical City where I 
spent 4 years. Subsequently I did a one year Fellowship in 
Neurorehabilitation at Wake Forest Baptist Medical Center  
North Carolina followed by another one year Fellowship in 
Interventional Rehabilitation at the same institute. I did 
not realize until recently that I have started to analyze 
impairment groups from three different perspectives 
based on my observations and experiences in different 
parts of the world. I have observed that not only disability 
arising from a neurological illness manifests differently in 
different  cultures, but also the rehabilitation strategies 
tend to vary differently in various regions of the globe for 
the exact same pathology. This goes way beyond what we 
find in our textbooks. Imagine an object in 3-dimensional 
space and make a note of its surroundings.  Now place 
S H O R T  C O M M U N I C A T I O N
that imaginary object in an entirely different location.  The 
object itself has not changed, but the background, 
brightness, colors, orientation and aura have changed.  
Does this also change your our perception towards that 
object?  It likely does.  Similarly, the pathophysiology of 
stroke remains unchanged  globally, but it has a 
completely different outlook in different regions of the 
world.  The perception of stroke rehabilitation then 
changes dramatically when you travel across continents.  
Across many fields of medicine, money poured into 
research disproportionately favors the studying of 
pathologies of high-income countries.3 Leading authors 
and modern textbooks in rehabilitation medicine come 
from developed health systems.  Many advanced 
treatment options are probably not applicable to most of 
the global disability population because disability 
prevalence tends to be higher in low income countries.  In 
Pakistan, when I used to read the current textbooks of 
Rehabilitation, most of my understanding of rehab was 
imaginative, hypothetical and impractical.  I was fortunate 
to have a great mentor who directed my thoughts toward 
the broader aspect of rehabilitation i.e social reintegration 
and empowerment.  The critical issue is not how stroke is 
affecting your body and environment; it is actually how the 
environment is affecting the body and stroke.  When you 
change the environment, you can change the pattern of 
stroke-related impairments.  A successfully trained and 
independent stroke patient in the U.S may likely have to 
undergo a refresher course of rehabilitation if he were 
brought to Pakistan, and vice versa.  The manner in which 
external factors interact with the patient is relevant to 
rehabilitation, but this remains a less emphasized topic of 
teaching in rehabilitation medicine.  During our training, 
much importance is given to activities of daily living 
(ADLs).  The functional Independence Measure (FIM) is 
one of the most popular scales for functional assessment 
across settings; however, is it universally valid?  Studies 
suggest that the FIM scale has strong interrater reliability 
when used by clinicians in the United States.4 Language 
and other cultural barriers have been shown to impact 
functional assessment scales in other specialties.5 In 
Saudi Arabia and Pakistan, the majority of the population 
is Muslim and performing prayers five times a day is a 
common practice.  This requires an individual to perform 
ablution before the prayers, which involves washing 
different parts of the body from head to toe.  Though there 
are exceptions made for performing ablution during 
illness, many patients still prefer to perform this practice.  
Similarly, the toileting practices vary from culture to 
culture.  Considering that, I sensed a dire need for a 
modified functional assessment scale for my patients 
during my residency.  In today’s globalized world, 
physicians are routinely expected to have a broad 
understanding of alternative and culturally determined 
medical practices.6 Gender preferences, sexuality, and 
social norms are unique to different cultures.  For 
example, in Pakistan, regardless of the socioeconomic 
status of the patient or family, discharge disposition is 
barely a problem because of conventional strong family 
support. In contrast, the Ministry of Health Hospitals in 
Saudi Arabia continue to provide services to all admitted 
patients until their disposition is finalized.  Furthermore, it 
is estimated that between 10% and 30% of all 
hospitalizations in Saudi Arabia require a need for medical 
rehabilitation, and ineffective implementation of current 
laws have resulted in services not being rendered in the 
most efficient ways.7,8 In most rehabilitation settings, 
there are no insurance issues and few financial pressures 
involved in expediting a patient`s discharge or arranging 
equipment.  Consequently, patients get a chance to stay 
longer as inpatients and benefit accordingly.  In the U.S, 
continuity of rehabilitation care post discharge is 
exemplary, whereas in Pakistan and Saudi Arabia, the 
concept of primary care physician is lacking and 
community-based rehabilitation is still very primitive. 
During my training in the U.S, I am able to relate to the 
materials in my textbooks more closely.  Now, not only do 
I observe the latest management strategies, but I also 
practice them as well. That reminds me of the early days 
of my career in Pakistan.  There was a patient who came 
for treatment of frozen shoulder. He travelled hundreds of 
kilometers to reach a tertiary care facility with very little 
money.  Like many patients coming to our outpatient 
facility, we knew that he was there for the first and last 
time.  This is an example of socioeconomic challenges in 
the management of frozen shoulder.  Nowhere in any 
textbook would one come across any recommendations 
that would address the successful management 
guidelines in these circumstances that are common in the 
developing world.  How does one tailor patient 
management in similar situations?  What are the best 
options for a patient who would not be able to follow up 
with any clinician after his initial visit?  These are 
important questions, since the medically underserved 
suffer higher rates of disease morbidity.9 It is true that 
most guidelines are evidence-based, and evidence is 
usually collected by research.  But for practical purposes, 
resources are not adequate to meet the growing demands 
of research in developing world.
I have used the term ‘three-dimensional’ based on my 
experience in neurorehabilitation in three entirely different 
regions of the world namely Pakistan, Saudi Arabia and 
United States. These medical models represent a sample 
of three different levels of health care systems around the 
globe. i.e underdeveloped, developing and developed 
health system respectively . In fact, I intend to propose 
the idea that rehabilitation of a particular neurological 
impairment or impairment group needs to be explored 
along different geographical dimensions so that the 
diversity of global rehabilitation practices can be brought 
onto a single platform.  The most ideal platform, in my 
opinion, would be the popular textbooks of neurological 
rehabilitation.  Conferences and exchange programs 
provide a concentrated opportunity but even the largest 
conferences are attended by a limited number of 
clinicians. Their impact remains restricted to the 
attendees or to readers who follow literature updates. 
Ideas and innovations are the crux of rehabilitation 
sciences.  Many educational and health systems in the 
developing world do not have the capacity to support 
extensive research to validate potentially effective ideas.  
Hence, these ideas remain hidden from the world and 
never get a chance to reach across borders.  These 
practices may never get published even in local literature, 
and even if they do, the local readership may be negligible 
due to lack of access or interest.  Textbooks, however, 
remain a common source of reference for residents, 
supervisors and physicians in all academic settings 
globally.  Colleagues that are critical members of the 
team, such as therapists and nurses, can benefit from 
this as well, as cultural and sociopolitical differences 
among patients affects their approach to healthcare as 
well.10  At the completion of students’ training, the test of 
their knowledge and skills usually revolve around 
information contained in textbooks. 
It is deemed important to have a textbook of neuro 
rehabilitation featuring writers from all around the globe. A 
key chapter on a particular topic could be followed by brief 
addendums from experts from different regions of the 
world. The regional authorship could be classified based 
on socioeconomic and cultural similarities.  For example, 
North America, Europe, Russia and Australia could be 
grouped together, while China and culturally similar 
neighboring countries could be grouped together.  South 
America, the Middle East, Africa and South Asia could 
have separate addendums. Similarly, regions under war 
could be grouped together.  This approach would yield a 
bulk of knowledge ranging from evidence-based practices 
to regional practices. In this manner, thousands of 
trainees and specialists who rely upon rehab textbooks 
could become more knowledgeable with regard to both 
regional and international trends. This would also facilitate 
the input of regional representation on an international 
platform and promote local authorities in their respective 
fields of interest.  In this manner, we could strengthen our 
knowledge of the rehabilitation process through a 
multidimensional process.
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Appendix A
Epilepsy in Pakistan: Classification and Diagnosis 
Guidelines for Clinicians:
QUESTIONS ADDRESSED 
Q1-Definition of Epilepsy: Adapted from New definition of 
ILAE review statement 2104
Q2-Q5-Classification of seizures, Epilepsy and epilepsy 
syndromes and etiologic basis
Q5-Q10-Diagnosis (history, physical exam, relevant lab 
tests, EEG, Neuroimaging)
Definition of Epilepsy: 
In 2013 an international taskforce of the ILAE shaped out 
a communal definition of Epilepsy.(2) This definition is useful 
for all or most practical purposes, thus more helpful in 
management. Epilepsy was defined as recurrent 
unprovoked seizures i.e 2 or more at least 24 hours apart. 
The revised practical definition implies that Epilepsy can be 
considered even after a single seizure in individuals who 
have other factors predictive of a second unprovoked 
seizure, a risk set at 60%. The factors include the diagnosis 
of an epilepsy syndrome, structural lesions like stroke, CNS 
infections, intraparenchymal contusions after trauma, as 
well as reflex seizures such as photosensitive seizures. (3)
Table 1 (2)
A person is considered to have epilepsy if they meet any 
of the following conditions:
At least two unprovoked (or reflex) seizures occurring 
greater than 24 hours apart.
One unprovoked (or reflex) seizure and a probability of 
further seizures similar to the general recurrence risk (at 
least 60%) after two unprovoked seizures, occurring over 
the next 10 years or the diagnosis of an epilepsy 
syndrome is clear. 
The Seizure: 
A seizure is defined as a clinical manifestation of 
abnormal discharges of a group of cortical neurons. For 
the purpose of these guidelines seizures are divided into 
two main categories 
Focal/Partial and Generalized. 
Focal seizures or partial arise from a focal point in the 
brain that can be identified by history. An aura is always a 
sign of a focal seizure. Focal seizures can be simple partial 
or complex partial. Generalized seizures do not have an 
identifiable focal point and involve entire brain at the 
onset. 
Simple Partial Seizures 
• Locus
 – one site or lobe
• Manifestations
 – Duration: ~30secs
 – Involuntary muscle jerks, sensory (tastes or  
  smells), psychic or emotional (fear)
 – Foul smell, metallic taste, light-headedness,  
  bright light, rising sensation in stomach.
• Consciousness
 – Retained
Complex Partial Seizures
• Locus 
 – One or multiple sites, TLE
• Manifestations
 – Duration: 1-3 min
 – Automatisms (picking at clothes, lip smacking,  
  wandering, repeating words)
 – May begin with SPS (aura)
• Consciousness
 – loses consciousness
Generalized Seizures 
• Primary generalized
 – Locus: both hemispheres affected from outset
 – Manifestation: 
  • Duration ~2mins
  • Muscles rigid(tonic)-person falls down,  
   rhythmic muscle contractions (Clonic),  
   shallow breathing, incontinence, post  
   ictal drowsiness, and confusion
  • Usually no aura or warning
  • Consciousness is lost
• Secondarily generalized
 – Preceded by SPS or CPS
• 
• 
Neonatal Seizures
• Odd presentation
• Not follow usual classification of Partial and   
 generalized seizures
• Focality very difficult to assess
Clinical Seizure
• Subtle
• Tonic
• Clonic 
• Myoclonic
Table 2.
Table 3.
Table 4.
Seizure Types :(20)
• Simple Partial and Aura
 – Consciousness retained 
• Complesx partial 
 – Consciousness impaired 
• Secondarily generalized 
 – Seizures that begin with a focal onset like aura, or 
evolve from partial onset and progress to generalized seizure
Simple partial and complex partial with or without 
generalization are considered focal when groped into 
syndromes
• Generalized 
 – Tonic
 – Clonic
 – Tonic clonic
 – Atonic
 – Absence
  • Typical 
  • Atypical
 – Absence  with special features – Myoclonic 
absence ; Eyelid myoclonia  
 – Myoclonic
 – Myoclonic aestatic 
• Unknown Epileptic spasms
• Non epileptic Seizures
(Seizures that cant be clearly diagnosed into one of the 
preceding categories should be considered unclassified 
until further information allows for their accurate diagnosis)
EPILEPSY SYNDROMES
• Often provides information on how long the seizures 
persist and which medications can be useful and which to 
avoid. 
• Defined by a cluster of characterstics
 – seizure type
 – EEG findings
 – neurologic status
 – age at onset
 – family history 
 – prognosis
For the sake of brevity and practical applicability of these 
guidelines the syndromes are simplified in few main 
categories 
Overall three categories in adults three more in children
1. Idiopatic Generalized Epilepsy (IGE) (Juvenile myoclonic 
epilepsy, absance, GTC, tonic, atonic)
2. Symptomatic localization related epilepsy(SLRE) 
 – Temporal lobe epilepsy
 – Frontal lobe epilepsy
 – Occipital lobe epilepsies 
3. Symptomatic Generalized Epilepsy eg Lennox- Gastaut 
syndrome
4. Other Epilepsies like Febrile seizures
5. West syndrome (Infantile spasms)
6. Benign rolandic epilepsy in children
Others like Reflex epilepsies and metabolic syndromes 
A detailed list of Epilepsy syndromes is outlined in table 5. 
Table 5
EPILEPSY SYNDROMES: (21-22)
Epilepsy syndromes arranged by age at onset 
• Neonatal period 
 – Benign familial neonatal epilepsy (BFNE) 
 – Early myoclonic encephalopathy (EME) 
 – Ohtahara syndrome 
• Infancy 
 – Epilepsy of infancy with migrating focal seizures 
 – West syndrome
• Myoclonic Epilepsy in infancy (MEI) 
 
Benign infantile epilepsy 
Benign familial infantile epilepsy 
Dravet syndrome 
Myoclonic encephalopathy in nonprogressive disorders 
Panayiotopoulos syndrome 
Epilepsy with myoclonic atonic (previously astatic) seizures 
Benign epilepsy with centrotemporal spikes (BECTS) 
Autosomal-dominant nocturnal frontal lobe epilepsy 
(ADNFLE)
Late onset childhood occipital epilepsy (Gastaut type) 
Epilepsy with myoclonic absences 
Lennox-Gastaut syndrome 
Epileptic encephalopathy with continuous spike-and-wave 
during sleep (CSWS)
Landau-Kleffner syndrome (LKS) 
Childhood absence epilepsy (CAE) 
Adolescence – Adult 
Juvenile absence epilepsy (JAE) 
Juvenile myoclonic epilepsy (JME) 
Epilepsy with generalized tonic–clonic seizures alone 
Progressive myoclonus epilepsies (PME) 
Autosomal dominant epilepsy with auditory features 
(ADEAF) 
Other familial temporal lobe epilepsies 
Less specific age relationship 
Familial focal epilepsy with variable foci (childhood to 
adult) 
Reflex epilepsies 
Distinctive constellations (lesion related symptomatic)
Mesial temporal lobe epilepsy with hippocampal 
Sclerosis (MTLE with HS) 
Frontal lobe Epilepsy (FLE)
Occipital Lobe Epilepsy (OLE)
Rasmussen syndrome 
Gelastic seizures with hypothalamic hamartoma 
Hemiconvulsion–hemiplegia–epilepsy 
Epilepsies that do not fit into any of these diagnostic 
categories can be distinguished first on the basis of the 
presence or absence of a known structural or metabolic 
condition (presumed cause) and then on the basis of the 
primary mode of seizure onset (generalized vs. focal) 
Epilepsies attributed to and organized by structural- 
metabolic causes 
Malformations of cortical development (hemimegalencephaly, 
heterotopias, etc.) 
Neurocutaneous syndromes (tuberous sclerosis complex, 
Sturge-Weber, etc.) 
Tumor 
Infection 
Trauma 
Angioma 
Perinatal insults 
Stroke 
Etc. 
Epilepsies of unknown cause 
Conditions with epileptic seizures that are traditionally not 
diagnosed as a form of epilepsy per se 
Benign neonatal seizures (BNS) 
Febrile seizures (FS) (22)
Childhood 
Febrile seizures plus (FS+) (can start in infancy) 
Panayiotopoulos syndrome 
Epilepsy with myoclonic atonic (previously astatic) 
seizures 
DIAGNOSIS
Making the correct diagnosis is the key to all 
management. In PWE there are major health, educational 
and psycho-social implications. It is most important that 
the physician is sensitive to PWEs and their families when 
communicating the diagnosis of epilepsy. Epilepsy 
remains a clinical diagnosis and it can be difficult. 
Misdiagnosis is frequent about 25% of cases in developed 
countries, much higher particularly when made by non 
neurologists. This itself can cause social and financial 
losses due to the wrong label, not to mention the side 
effects of unnecessary treatment as well. Conversely 
Individuals may die because diagnosis was not made. The 
diagnosis of Epilepsy remains a clinical diagnosis with all 
tests providing supplementary data. 
History                                                            
• A detailed history should be taken from the child, 
young person or adult 
• An eyewitness to the attack, where possible, to 
determine whether or not an epileptic 
seizure is lllikely to have occurred.
• The clinical decision as to whether an epileptic 
seizure has occurred should then be based on the 
combination of the description and the different 
symptoms. 
• Diagnosis should not be based on the presence or 
absence of a single feature.
Physical Exam
PWE presenting with a seizure, a physical examination 
should be carried out. Vitals, inspection of skin, in children 
a general physical especially abdominal to r/o hepato- 
splenomegaly.
Include their cardiac, neurological and mental status and 
in case of children a developmental assessment where 
appropriate. [18] 
Follow-up should always be arranged 
Where non-epileptic attack disorder is suspected, first rule 
out organic cause then make suitable referral to 
psychological or psychiatric services for further 
investigation and treatment.
Epilepsy: Differential Diagnosis
• Many other conditions may be confused with 
epilepsy:
–  syncope - reflex, cardiac, postural
–  Psychogenic non epileptic seizures PNES
–  TIA
–  panic attacks
–  sleep disorders
–  hypo/hyperglycemia
–  migraine
–  Vertigo
– intra ventricular colloid cyst, 
– cataplexy, 
– Acute symptomatic seizure secondary to 
hypoglycemia, alcohol intake, alchohol withdrawal, 
hyponatremia, eclampsia etc.
Differentiating seizures from syncope/LOC
Questions to ask and if “yes”, support a diagnosis of 
epileptic seizure: 
•  At times do you wake up with a cut tongue after your 
spells? 
•  At times do you have a sense of déjà vu or jamais vu 
before your spells? 
•  At times is emotional stress associated with losing 
consciousness? 
•  Has anyone noticed your head turning during a spell? 
•  Has anyone ever noted that you are unresponsive, have 
unusual posturing or have jerking 
limbs during your spells or have no memory of your spells 
afterwards? 
• Has anyone noticed that you are confused after a 
spell?
• Have you had any episodes while lying down or during 
sleep? 
Questions if “yes”, support a diagnosis of syncope: 
• Have you ever had light-headed spells? 
• Are all your attacks during the erect position?
• At times do you sweat before your spells? 
Differentiating PNES with NES
Questions if “yes” support a diagnosis of PNES:
• Are all events during waking?
• Are you aware of the surroundings while you are 
unable to respond?
• Is there pelvic thrusting and bicycling that lasts for 
more usually longer than a couple of minutes. 
• Do they always occur in the presence of someone or 
during an argument?
• Do they last for hours ?
• Do they wax and wane over the span of hours with no 
stereotype?
Questions if “yes” support a diagnosis of ES: 
• Are the episodes stereotyped and brief?
• Do they occur during sleep?
• Are they associated with incontinence?
• Is there tongue bite on lateral edges of the tongue?
In Children
Breath holding spells, febrile fits, syncope, parasomnias, 
behavioral issues should be differentiated. 
Role of Home video”s and written discrptions
Prospective recording of events, including video recording 
and written descriptions, can be very 
helpful in reaching a diagnosis.
 
Investigations 
A range of investigations, chiefly EEG and brain imaging, 
are available to assist the clinician in Classifying seizures 
and epilepsy syndromes of individuals suspected as 
having epilepsy. 
Q. The role of EEG in making a diagnosis of epilepsy :
1. An EEG should be performed to support a diagnosis 
of epilepsy in PWE in whom the 
clinical history suggests that the seizure is likely to be 
epileptic in origin.  
2. The normalEEG should not be used to exclude a 
diagnosis of epilepsy in PWE in whom 
the clinical presentation supports a diagnosis of a 
non-epileptic event. 
3. The EEG should not be used in isolation to make a 
diagnosis of epilepsy. 
6. The EEG should be reported by a qualified 
neurophysiologist to minimize over/under reporting.  
These not being available arrangements for workshops 
and doubtful tracings to be sent to qualified 
neurophysiologists be made. 
7. The finding of interictal epileptiform activity on EEG 
can be used to help confirm the 
Clinical diagnosis of an epileptic seizure.  A negative EEG 
cannot be used to rule out the
clinical diagnosis of an epileptic seizure.                                                      
8. When a standard EEG has not contributed to 
diagnosis or classification, a sleep EEG should be 
performed.A sleep EEG is best achieved through sleep 
deprivation or the use of 
Melatonin
9. A routine EEG should include activation procedures 
like photic stimulation and hyperventilation if not 
contraindicated due to state and condition of the patient.
10. Chloral hydrate, clonazepam (in children) and 
midazolam, diazepam or other benzodiazepines should 
not be used to sedate the patient prior to EEG.
11. When Temporal lobe Epilepsy is in the differential 
extra anterior tempotal leads should be applied T1 and T2 
preferably
12. When occipital lobe involvement is in the differential 
or occipital discharges are noted a posterior halo or 
headband montage should be used. 
13. Longterm video EEG should be used in PWE  who 
present with diagnostic difficulties after clinical 
assessment and standard EEG is not supportive or 
questionable as well as PNES suspected cases. 
The role of neuroimaging in the diagnosis of epilepsy 
Neuroimaging should be used to identify structural 
abnormalities that cause certain epilepsies. 
It is recommended in patients with focal onset seizures or 
multifocal seizures or when there is an acute change in 
seizure semiology and frequency in a compliant previously 
controlled PWE.
1. MRI should be the imaging investigation of choice in 
children, young people and adults with epilepsy. (specified 
seizure protochol see appendix)
MRI is particularly important in those: 
• who develop epilepsy before the age of 2 years or in 
adulthood 
• who have any suggestion of a focal onset on history, 
examination or EEG (unless clear 
evidence of benign focal epilepsy) 
• in whom seizures continue in spite of first-line 
medication. 
2. Neuroimaging should not be routinely requested 
when a diagnosis of idiopathic 
generalized epilepsy has been made.
3. CT should be used to identify underlying gross 
pathology if MRI is not available or is contraindicated, and 
for children and young people  in whom a general 
anaesthetic or sedation would be required for MRI but not 
CT. The CT should be at least 64 slice scanner and thin 
cuts with axial and coronal views. 
4. In an acute situation, CT may be used to determine 
whether a seizure has been caused by an acute 
neurological lesion or illness.  
The Seizure Protocol MRI : Special Thanks to 
Dr. Zafar Sajjad, Professor, Department Of Radiology,
Aga Khan University, Karachi.
Recommendations
• MRI request should say Seizure protocol
• Though a screening protocol has been put in the end 
it is important to reiterate that screening MRIs for strokes 
and tumors on low field strength machines (becoming a 
norm through Pakistan) is a false economy for Epilepsy. 
• All MRI centers should have the protocol and guide 
the patient if they do not have the specifics. 
Protocol Considerations
1. Axial  T1 and T2  images standard SE/TSE 5mm should 
be done in all cases. 
2. Fluid inversion (FLAIR) sequences in Coronal Plane in 
all PWE
3. Gadolinium contrast enhancement increases the cost 
further and  is not necessary in routine cases but helpful 
in selected cases  In patients where sedation or GA is 
required to enable the test the cost of not doing the 
contrast scan may be higher if the entire procedure is to 
be repeated.
Patients should have at least 1 contrast enhanced scan in 
the course of their disease.
4. Coronal Flair and T2 images in all seizure protocols 
irrespective of whether contrast is given or not. If contrast 
is given post contrast coronal should also be taken. 
5. If temporal lobe epilepsy is in the differential : Coronal 
FLAIR and High Resolution, thin section T2 sequences 
perpendicular to the long axis of the hippocampus, with 
and without contrast.
6. If cortical dysplasia is suspected:  Sagittal  T1 along 
with  Axial T1, T2 FSE/TSE , Axial FLAIR  Axial DWI / ADC . 
Coronal T2,  and  3D Volume GRE – T1, thin-section, 
whole brain but  If there is a known EEG focus  then do the 
coronal thin T2 and FLAIR (from the MTS protocol) in the 
suspicious EEG location. If any abnormality noticed, then 
give contrast. NOTE: This will apply only to the paediatric/ 
adolescent population.  In this a T1 GRE volume and a T1 
IR sequence would be sufficient.  DWI is now standard of 
care on all brain MRIs and should be acquired irrespective 
of indication.
7. T1 GRE volumes and T1 IR axial slices in all patients 
below the age of 18 years.
Recommendation for a Standardized Seizure 
protocol MRI:
Should only be carried out on a high field strength (1.5T 
or above) magnet
Axial TSE T2 5mm
Axial SE T1 5 mm
Coronal  FLAIR 5mm
Coronal High Resolution T2 perpendicular to the 
hippocampus
Axial DWI min b=1000
Post contrast Axial T1 and FLAIR coronal
For the paediatric age group add:
T1 GRE volume.  Primary acquisition in the coronal plain.
T1 IR Axial or coronal
For focal seizures or secondary generalization add
SWI Axial
eople (9)
Show details
Laboratory tests
1. Measurement of serum prolactin is not 
recommended for the diagnosis of epilepsy. 
2. In adults, appropriate blood tests (for example, 
plasma electrolytes, glucose, calcium) to 
identify potential causes and/or to identify any significant 
co-morbidity should be considered.  
3. In children and young people, other investigations, 
including blood and urine biochem 
should be undertaken at the discretion of the specialist to 
exclude other diagnoses, and to 
determine an underlying cause of the epilepsy.  
4. B12, vitamin D and serum iron, Mg, Ca, LFTs and 
serum creatine kinase, complete blood count, creatinine 
should be checked especially when on AED’s. 
Cardiovascular tests as an aid to diagnosis 
 1.  A 12-lead ECG should be performed in adults over age 
30 with suspected epilepsy. 
2.  In children and young people, a 12-lead ECG should 
be considered in cases of diagnostic 
uncertainty. 
3. In cases of atypical attacks and strong possibility 0f 
syncope or any arrhythmia on EKG,  a referral to a 
cardiologist should be considered. 
 
The role of neuropsychological assessment in the 
diagnosis and management of epilepsy? 
Neuropsychological deficits are commonly associated with 
epilepsy and its treatment.  Awarenes of these problems 
may facilitate education, social integration and 
employment
1. Neuropsychological assessment should be 
considered in children, young people and adultin whom it 
is important to evaluate learning disabilities and cognitive 
dysfunction,
 particularly in regard to language and memory. 
2. when a child, young person or adult  with epilepsy is 
having educational or occupational 
difficulties 
3. when an MRI has identified abnormalities in 
cognitively important brain regions 
4. when a child, young person or adult complains of 
memory or other cognitive deficits and/or cognitive 
decline. 
 
Conclusion
The primary scope of these guidelines is to provide a 
concise practical plan which will help identify the seizure, 
and classify it in the simplest possible form. These 
guidelines hope to provide the physicians treating epilepsy 
patients with a step wise approach to the diagnosis 
patient with epilepsy. Though some of these diagnostic 
tests are expensive making the correct diagnosis at an 
initial stage of the disease can same much in long term 
cost of morbidity and polypharmacy.
A health care structure needs to be created on the 
governmental level to provide subsidized AEDs and 
diagnostic facilities.
These guidelines will be revisited and modified on 
applicability every four years. People with epilepsy remain 
at the centre of this guideline, and the need for services 
to consider the needs of each individual and their care 
givers have been focused. 
Appendix B
EPILEPSY IN CHILDREN AND NEONATES
Diagnosis: 
Making the correct diagnosis is extremely important in 
children due to long term implications like educational, 
psychosocial, intelligence quotient, development, self 
esteem and the psychological impact on their parents. 
Misdiagnosis is more common in peads than in adults, 
particularly when diagnosis is made by non specialists. 
Recognizing and classifying seizures is different in 
neonates , infants and children as does the etiology and 
management.
 
Classification:  
See Appendix A
Treatment: 
The basic principles of AED treatment in children with 
epilepsy (CWE) remain the same as in adults. CWE should 
be encouraged to participate in normal activities with their 
peers , supervised where needed depending on the type 
of activity and seizure history. Parents of CWE should be 
advised not to be over protective. 
NEONATAL SEIZURES
Diagnosis of neonatal seizures is essentially clinical and 
must be based on observation of repeated or rhithmic 
activity which is (subtle) for example orofacial twitching, 
(clonic) limb movements, jerking not stopped when held,  
autonomic disturbances, stiffening (tonic) or sustained 
posturing of limbs. Home video of events is helpful in 
diagnosis and further management of such neonates 
needs to be done under specialized care. 
Table 1: Causes of Neonatal seizures
Ideal Metabolic Evaluation should include:
•  Blood:  glucose, lytes, BUN, creatinine, lactate, 
pyruvate, ammonia, biotinidase, quantitative amino acids, 
very long chain fatty acids
• Urine:  quantitative amino acids
• CSF:  cell count, glucose, protein, pyruvate, lactate, 
quantitative amino acids, HSV PCR
Unfortunately these are very costly and some need to be 
sent abroad increasing cost.  
General Recommendations
• All neonates with seizures should be given pyridoxine 
50-100mg 
• Neonatal screening TSH, 
• lactic acid, if acidosis biotin should be given and 
acidosis corrected.
•  serum AA and urine organic acids if inborn errors 
suspected e.g. sibling history or consanguineous marriage.  
• Stabilize vital signs and  treat underlying hypotension
• Correct transient metabolic disturbances
• Phenobarbital is first line agent
• Lorazepam and Phenytoin second line 
• Valproate and Levitiracetam if myoclonic fits.
• See table for oral AEDs that can be used
• Refer to Pediatric Neurologist ASAP
Table 3. Oral AEDs that can be used in Neonatal seizures 
 
Acute Therapy of Neonatal seizures : 
If with hypoglycemia- Glucose 10%: 2ml/k IV
If no hypoglycemia- Phenobarbital:20mg/k IV
       loading dose
       If necessary : additional phenobarbital:
       5 mg/kg IV to a max of 20 mg/kg
       (omit if respiratory compromise)
        Phenytoin: 20 mg/kg, IV (1 mg/kg/min)
        Lorazepam:0.05-0.10 mg/kg, IV  
All neonates with intractable seizures should be given 
50-100mg iv pyridoxine.
FEBRILE SEIZURES or FITS (FF)
1. Fits that occur in otherwise normal infants from age 6 
months to 6years on during high fever greater than 101oF 
or 38oC. (fever not caused by meningeal or cerebral 
infection)
2. Single FF occurs in 3-5% of children. Recurrent FF 
occurs in one third of children with FF. Recurrance is 
higher if first FF within first year of life.
3. FF may be simple or complex and this helps 
prognosticate the FF. Simple is brief, generalized <1min. 
Complex FF comprise only 15% of FF, usually partial onset, 
longer >15 minutes or multiple fits in the same illness. 
These are more likely to develop epilepsy in the future. 
4. LP (lumbar puncture) should be done in children 
suspected of CNS infection 
5. Recurrent simple FF do not warrant investigation and 
need parental counseling 
6. EEG is not required in Simple FF. it should be done in 
complex FF, febrile status epilepticus. 
7. FF is never focal
8. Neuroimaging has no role in simple FF
9. FF counseling should include lowering body 
temperature, acutely acting antiepileptic drugs like 
diazepam  orClobazam 0.75mg/kg in two divided doses, 
or phenobarbitone prophylactically during fever only. 
10. Continued prophylaxix with AEDs is not recommended 
in FF. 
11. Parents need to be taught the use of rectal diazepma 
0.5mg/kg and/or buccal midazolam (0.2-0.3mg/kg) for 
acute termination of seizure if lasts longer than 2 minutes. 
12. Parents should be cautious not to let fever rise in 
such children
CHILDHOOD Specific EPILEPSY SYNDROMES: 
(pharmachologic management)
Pharmacological management of ABSENCE 
SEIZURES 
1. Ethosuximide or sodium valproate as firstline treatment 
to children, patients with
absence seizures. If there is a high risk of GTC seizures, 
offer sodium valproate first, 
unless it is unsuitable. Be aware of teratogenic risks of 
sodium valproate. NOTE: Ethosuximide is not available in 
Pakistan.
2. Lamotrigine if ethosuximide and sodium valproate are 
unsuitable, ineffective or not tolerated. 
3. If two firstline AEDs  are ineffective in patients with 
absence seizures, consider a combination of two of these 
three AEDs as adjunctive treatment: ethosuximide, 
lamotrigineor sodium valproate. Be aware of teratogenic 
risks of sodium valproate  
4. If adjunctive treatment is ineffective or not tolerated, 
discuss with, or refer to epilepsy specialist and consider 
clobazam, clonazepam, levetiracetam, topiramate,or 
zonisamide (not available in Pakistan)
5. Do not offer carbamazepine, gabapentin, oxcarbazepine, 
phenytoin, pregabalin, tiagabine or vigabatrin.
6. Avoid VPA with clonazepam in childhood absences it 
can induce absence status
Pharmacological management of myoclonic seizures 
1. Offer VPA as first-line treatment to children, with  newly 
diagnosed myoclonic seizures, 
unless it is unsuitable. 
2. Offer LEV or TPM if VPA is not suitable or patient not 
responding
(Be aware that TPM has a less favourable sideeffect 
profile than LEV and VPA) 
3. Offer LEV, VPA or TPM as adjunctive treatment to 
children, with myoclonic seizures if firstline treatments are 
ineffective or not tolerated. Be aware of teratogenic risk of 
VPA 
4. If adjunctive treatment  is ineffective or not tolerated, 
discuss with, or refer to, epilepsy specialist and consider 
clobazam,clonazepam, piracetam or zonisamide or 
steroids. 
5. Do not offer carbamazepine, gabapentin, oxcarbazepine, 
phenytoin, pregabalin, tiagabine or vigabatrin. 
 
Pharmacological management of INFANTILE SPASMS 
1. Discuss with, or refer to, a tertiary paediatric epilepsy 
specialist when an infant presents with infantile spasms. 
These children will need polytherapy.
2. Offer a steroid (prednisolone or tetracosactide or ACTH) 
or vigabatrin with VPA as first-line treatment to infants with 
infantile spasms that are not due to tuberous sclerosis. 
Carefully consider the risk-benefit  when using vigabatrin 
or steroids. 
3. Offer vigabatrin with VPA as first-line treatment to 
infants with infantile spasms due to tuberous sclerosis. If 
vigabatrin is ineffective, offer a steroid (prednisolone or 
tetracosactide Carefully consider the risk-benefit when 
using vigabatrin or steroids. 
Pharmacological management of Dravet syndrome 
1. Discuss with, or refer to, a tertiary paediatric epilepsy 
specialist when a child presents with suspected Dravet 
syndrome. 
2. Consider VPA or TPM as first-line treatment in children 
with Dravet syndrome. 
3.If first-line treatments in patients with Dravets syndrome 
are ineffective or not tolerated try clobazam or stiripentol 
(* not available in Pakistan) as adjunctive treatment. 
4. Do not offer CBZ, gabapentin, LTG, OXC, PHT, 
pregabalin, tiagabine or vigabatrin.  
Pharmacological management of LENNOX-GASTAUT 
SYNDROME 
1. Discuss with, or refer to, a tertiary paediatric/ epilepsy 
specialist when a child presents 
with suspected Lennox–Gastaut syndrome. Most require 
poly-therapy
2. Offer VPA as first-line treatment to children with 
Lennox–Gastaut syndrome.   
3. Offer LTG, TPM as adjunctive treatment if first-line 
treatment with VPA is ineffective or not 
tolerated.  
4. Other AEDs that may be considered by the tertiary 
epilepsy specialist are rufinamide and topiramate and 
polypharmacy with benzodiazepines, trial of steroids may 
also be considered. 
5. Do not offer CBZ, gabapentin, OXC, pregabalin, 
tiagabine or vigabatrin. 
Pharmacological management of BENIGN EPILEPSY 
WITH CENTROTEMPORAL 
SPIKES,(BECTS)
1. Discuss with the child, and their family whether AED 
treatment for benign epilepsy with 
Centro-temporal spikes, 
2. Offer LTG or CBZ* as first-line treatment.
3. Offer LEV, OXC*, or VPA(avoid in older girls) as 2nd line 
if above fail
(*Be aware that carbamazepine and oxcarbazepine may 
exacerbate or unmask continuous spike and wave during 
slow sleep, which may occur in some children with benign 
epilepsy with centrotemporal spikes. Be aware of 
teratogenic risks of VPA and rash with LTG.)
4. Consider adjunctive treatment if a second well-tolerated 
AED is ineffective. 
5. Offer clobazam, gabapentin, LTG, LEV, OXC, VPA, TPM, 
LCM if first-line treatments fails
Refractory childhood epilepsy syndromes adjuvant 
AEDs
Other AEDs that may be considered by the tertiary 
epilepsy specialist are eslicarbazepine 
acetate, pregabalin, tiagabine, vigabatrin, LCM, and 
zonisamide,PB, PHT, TPM,
Carefully consider the risk–benefit ratio when using 
vigabatrin due to irreversible visual field constriction in 
upto 30%  
Ketogenic diet, medical marijuana, methylprednisone, 
clobazam,  nitrazepam, clonazepam, lorazepam are also 
recommended in refractory cases. 
Note
• In children, the diagnosis and management of 
epilepsy within the first few years of life may be extremely 
challenging.  For this reason, children with suspected 
epilepsy should be referred to tertiary services early, 
because of the profound developmental, behavioural and 
psychological effects that may be associated with 
continuing seizures.  
• Behavioural or developmental regression or inability 
to identify the epilepsy syndrome requires immediate 
referral to tertiary services. 
• Children, young people and adults with specific 
syndromes such as Sturge–Weber syndrome, the 
hemispheric syndromes, Rasmussen’s encephalitis and 
hypothalamic hamartoma should be referred to a tertiary 
epilepsy service.  
• All PWE and learning disabilities should have a risk 
assessment including: 
• bathing and showering 
• preparing food 
• using electrical equipment 
• managing prolonged or serial seizures 
• the impact of epilepsy in social settings 
• SUDEP 
Annexure: RCT review and our modifications)
Partial Seizures: Children
Recommendations 
Level A: OXC
Level B: None (RTC) LTG (NICE)
Level C: CBZ, PB, PHT,TPM, VPA, VGB
Level D: LTG, ZNS, CLB, CZP
Level E: Others
Level F: None
Recomendations: PB*, VPA, CBZ, OXC, LTG, 
Generalized Tonic Clonic Seizures: Children
Recommendations
Level A: None
Level B: None
Level C: CBZ*,PB, PHT*,TPM,VPA
Level D: OXC* LEV, LTG, (considered first line NICE)
Level E: Others
Level F: None
*may aggravate tonic clonic seizures and more commonly 
other generalized seizure types, should be used with 
caution 
Women of childbearing age with epilepsy 
Introduction 
Most women with epilepsy who are receiving optimal 
treatment for their epilepsy, and who are well-informed, 
supported and fully counselled have uncomplicated 
pregnancies, normal deliveries, and healthy children. 
However in Pakistan no such proper program or 
counseling or management plan is available. Thus number 
of complications and perinatal problems are high in WWE 
(women with epilepsy). A number of issues need to be 
considered 
• Both the disease and its treatment may alter the 
menstrual cycle and fertility.  
• There are problems with drug interactions, particularly 
with hormonal contraceptives.  Some methods of 
hormonal contraception may not be as effective in women 
taking AEDS.  The effectiveness will depend on which 
AED(s) are being taken. Effective contraception has an 
additional importance in women with epilepsy because of 
the risks associated with an unplanned pregnancy to the 
women and the developing  fetus.  
• AEDs are associated with teratogenic effects.  
• Both AEDs and uncontrolled seizures can cause 
adverse effects during pregnancy.  
Conversely, pregnancy and menses can affect seizure 
control due to hormonally induced alteration of the seizure 
threshold.
• Every pregnancy is different. 
Management of Epilepsy in Women can be divided into 5 
phases: 
1. COUNSELLING
2. CONTRACEPTION
3. PREGNANCY
4. LABOUR
5. POST PARTUM AND LACTATION 
COUNSELLING 
• In order to enable informed decisions and choice, and 
to reduce misunderstandings, women  and girls with 
epilepsy and their partners, as appropriate, must be given 
accurate information and counselling about contraception, 
conception, pregnancy, caring for children and 
breastfeeding, and menopause.  
• All healthcare professionals who treat, care for, or 
support women and girls with epilepsy should be familiar 
with relevant information and the availability of counseling 
the risk of AEDs causing malformations and possible 
neurodevelopmental impairments in an unborn child.
• Assess the risks and benefits of treatment with 
individual drugs. There are limited data on risks to the 
unborn child associated with newer drugs. Specifically 
discuss the risk of continued use of sodium valproate to 
the unbornchild, being aware that higher doses of sodium 
valproate (more than 800 mg/day) and polytherapy, 
particularly with sodium valproate, are associated with 
greater risk. (see table drugs and teratogenicity)
CONTRACEPTION
1. CBZ, PHT, OXC, TPM and barbiturates reduce the 
effectiveness of oral contraceptives
 necessitating the use of alternative methods, or special 
highdose regimens of oral contraceptives.  Even with this 
precaution, the effectiveness of the oral contraceptive is 
reduced.  (Ia NICE) 
2. Hormone-releasing IUDs are effective as a method of 
contraception in women taking AEDs. 
3. There is limited evidence that progesterone implants 
(specifically levonorgestrel) are ineffective
 in women taking enzyme-inducing AEDs. 
4. Progesterone pill should be avoided. 
5. There is no evidence on the effectiveness of emergency 
contraception in women taking enzyme-
inducing AEDs. 
6. There needs to be a National Pregnancy registry.
PREGNANCY
7. AED’s should be continued in pregnancy. There is no 
benefit of stopping AED’s after 3-4 weeks of conception 
(nural tube formed), and risk of seizures outweighs risk of 
continued AED exposure in vitro. 
Table 12: AED’s and Pregnancy Risk: 
8. When should screening for structural fetal anomalies 
be performed in pregnant women 
with epilepsy? 
A recent NICE guideline reviewed the evidence on the 
detection of structural fetal abnormalities in healthy 
pregnant women.
It is recommended that ‘pregnant women should be 
offered an ultrasound scan to screen for structural 
anomalies, ideally between 18 to 20 weeks of gestation, 
by an appropriately trained sonographer and with  
equipment of an appropriate standard.
9. When should folic acid be started? 
• All women nd girls on AEDs should be offered 5mg
per day of folic acid before any possibility of pregnancy.  
• There is limited evidence to show that folic acid 
supplementation reduces the risk of
• Neural tube defects and other congenital 
malformations in women taking AEDs.   
• Women who are planning pregnancy should be 
advised to take 400mcg of folic acid from when they 
begin trying to conceive until the 12th week of pregnancy 
and that those who suspect they are pregnant and who 
have not been taking supplements should start folic acid 
supplements 5mg immediately and continue until the 
12th week of pregnancy.
10. Serum levels of AEDs are of help during pregnancy. 
The dose of AEDs should not be increased routinely if 
levels are low except if seizures start occurring, and at the 
time of delivery to avoid breakthrough seizures during the 
stress of labour. 
11. If preterm labor is threatened in women taking 
enzyme-inducing AEDs, 48mg betamethasone (double 
the normal dose) should be given over 48 hours. 
12. Vitamin K 10mg i.m. at 34 and 36 weeks is 
recommended for all women unless there is a 
contraindication. 
13. Some counseling points: 
What are the dangers of seizures in women who are 
pregnant or post-natal? 
• Women and girls with epilepsy need accurate 
information during pregnancy, and the possibility of status 
epilepticus and SUDEP should be discussed with all 
women and girls who plan to stop AED therapy 
• Women and girls with generalised tonicclonic seizures 
should be informed that the fetus may be at relatively 
higher risk of harm during a seizure, although the absolute 
risk remains very low, and the level of risk may depend on 
seizure frequency. 
• There is no evidence that simple focal, complex focal, 
absence and myoclonic seizures adversely affect the 
pregnancy or developing fetus.  
• Generalized tonicclonic seizures are likely to result in 
more profound hypoxia than in the nongravid state due to 
increased maternal oxygen requirements.  This may have 
adverse affects for the fetus
POST-CONCEPTION
14. Counselling about safety during child rearing, like to 
keep baby in a crib next to the bed, care to avoid dropping 
the baby especially JME.
15. Breast Feeding guide: All mothers should be 
encouraged to breast feed. 
16. The doseage of AEDs such as LTG, LEV, OXC may have 
to be reduced if they were raised during pregnancy but 
after 6 weeks post partum 
17. Spacing between pregnancies should be 
recommended and safe/ effective contraceptive methods 
should be offered to all WWE. 
MANAGEMENT OF STATUS EPILEPTICUS Guidelines 
for Pakistan:
When a convulsive seizure continues for a prolonged 
period (longer than 5 minutes), or when convulsive 
seizures occur one after the other with no recovery in 
between patient is considered to be in Status Epilepticus. 
Convulsive status epilepticus is an emergency and 
requires immediate medical attention. TREAT HARD and 
TREAT FAST 
APPENDIX : STATUS EPILEPTICUS PROTOCOL
Definition:  
1. Convulsive Status Epilepticus (CSE): in adults and 
children older than 5 years is characterized by continuous 
convulsive seizures lasting more than 5 minutes or two or 
more seizures in 20 minutes without gaining 
consciousness in between.
2. Non-convulsive status epilepticus (NCSE) is mental 
status changes from baseline for at least 30 minutes 
associated with ictal discharges on EEG. It should be 
suspected in patient after convulsive seizure who is not 
regaining consciousness. 
3. Refractory Status Epilepticus: (RSE) Seizure activity 
that continues after first and second line AED therapy 
have failed. This can be CSE and NCSE.
MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS:
PRE-HOSPITAL STAGE: FIRST 5-10 MINUTES
• Children: Rectal diazepam 0.5mg /kg or buccal 
midazolam 0.2-0.3mg/kg ; adults: rectal diazepam 10mg 
or buccal midazolam 10mg (home)
• Maintain iv line as soon as possible and administer 
5-10mg diazepam or 3-5 mg midazolam iv push followed 
by saline flush. (EMS)
• Secure airway, breathing and circulation
HOSPITAL STAGE: 5-20 MINUTES
• Diazepam 0.2mg /kg (maximum 10mg) over 
1minute,OR midazolam 0.2mg/kg ivp or im, upto 10mg;  
wait 5 minutes for seizures to terminate. Order and 
prepare IV phenytoin. If seizure terminates investigate 
cause of seizures further, if not repeat again .in children 
<2years give neurobioniv to replace thiamine and biotin. 
• Give Oxygen, stabilize airway, respitation and 
hemdynamic parameters, apply pulse oxymetry.
• Send RBS, LFT, renal functions, electrolytes, BUN, and 
CT scan. LP and CSF analysis if CNS infection suspected.
• Start PHT infusion 15-20mg/kg at maximum rate of 
50mg/min (1mg/kg/min in small children) AVOID dilution in 
glucose solution. Monitor heart rate and blood pressure, 
contraindicated in patients with heart block or hypotention 
SBP<95. (phosphenytoin 15-18mg PE/kg/min at max rate 
of 150mg PE/min is internationally the drug of choice but 
unfortunately not available in Pakistan)
HOSPITAL STAGE : ESTABLISHED GSCE 20-60minutes: 
• If seizures continue 5-10 mins after PHT, reload 
5-10mg/kg iv at same rates as above
• Seizures continue give Sodium Valproate 
25-35mg/kg at a rate of 6mg/kg/hr
• Arrange for intubation, anaesthesia on board
• Seizures continue give iv levitiracetam  loading 
1000-3000mg (adults) at 2-5mg/kg/min
• Seizures continue next stage RCE.
• Start phenobarbitone50-100mg/min IV loading dose, 
and if intubated can start infusion 0.5-5mg/kg/hr or skip 
to next stage RCE
HOSPITAL STAGE: Refractory Status Epilepticus 
(more than 60 mins)
• Prepare to intubate and transfer to ICU
• Start lacosamide 200-400mg IV 200 mg over 15 
mins (adults only)
• Ideally obtain central venous access and contiuous 
hemodynamic monitoring through arterial line and EEG 
monitoring
• Anaesthetic agents: Adults and children midazolam 
0.2mg/kg IV bolus followed by 0.1-0.4mg/kg/hour 
continuous iv infusion OR propofol 2-5mg/kg IV bolus 
followed by 5-10mg/kg/hr iv infusion OR thiopental 
10-20mg/kg IV bolus followed by 0.5-1mg/kg/hr IV infusion 
till EEG shows burst suppression (pharmacologic coma)
• Continue coma phase  for 12 hours after last seizure
• Weaning phase: reduce infusion of anaesthetic agent 
every 3 hours with EEG monitoring, if seizures recur 
re-institute coma with the same anaesthetic to the dose 
where seizures were responsive. 
• Add topiramate 200 mg bolus and 100 mg tid. 
• Identify and treat medical complications correct 
acidosis if pH 7.2 or if symptomatic in the form of cardiac 
disturbances. Vigorously treat infections, avoid penicillin 
and quinolone group of antibiotics. 
• If seizures continue and autoimmune or idiosyncratic 
modulation is suspected consider puse steroids and ivIG. 
POST STATUS PHASE
• Maintenance therapy, all AEDs that were used to 
treat the status should be continued on maintainance 
dosage till patient remains seizure free for at least 3-7 
days if patient awake, if GCS remains low gradually 
remove under EEG coverage.
P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S 41 V O L .  1 0  ( 4 )  O C T  -  D E C  2 0 1 5
The term three-dimensional, or 3-D, usually refers to an 
object’s existing along three different axes that intersect 
at specific angles.  The three axes, or dimensions, 
represent height, width and depth and determine the 
orientation and direction of an object in space.  Increasing 
the number of dimensions of an object from one or two to 
three greatly increases our perception and understanding 
of the object.  This even impacts our perception of 
characteristics of the object, such as color, that we may 
not suspect were related.1 Consider, then, the possibility 
of extending this “holistic” model to the rehabilitation 
process of patients with neurological disabilities. Could 
impairment categories such as stroke, brain injury or 
spinal cord injury be considered three dimensional? Yes, 
we might actually view and more fully understand any 
neurological impairment by exploring its multiple 
dimensions in different health systems around the globe. 
Recently, disability issues have taken on an increasingly 
prominent role on international stages.2 I started off my 
externship in Physical Medicine and Rehabilitation at 
Mayo Hospital Lahore Pakistan and joined the same 
department as a resident trainee. After spending a total of 
9 months there I was selected to continue to my 
residency training at King Fahad Medical City where I 
spent 4 years. Subsequently I did a one year Fellowship in 
Neurorehabilitation at Wake Forest Baptist Medical Center  
North Carolina followed by another one year Fellowship in 
Interventional Rehabilitation at the same institute. I did 
not realize until recently that I have started to analyze 
impairment groups from three different perspectives 
based on my observations and experiences in different 
parts of the world. I have observed that not only disability 
arising from a neurological illness manifests differently in 
different  cultures, but also the rehabilitation strategies 
tend to vary differently in various regions of the globe for 
the exact same pathology. This goes way beyond what we 
find in our textbooks. Imagine an object in 3-dimensional 
space and make a note of its surroundings.  Now place 
that imaginary object in an entirely different location.  The 
object itself has not changed, but the background, 
brightness, colors, orientation and aura have changed.  
Does this also change your our perception towards that 
object?  It likely does.  Similarly, the pathophysiology of 
stroke remains unchanged  globally, but it has a 
completely different outlook in different regions of the 
world.  The perception of stroke rehabilitation then 
changes dramatically when you travel across continents.  
Across many fields of medicine, money poured into 
research disproportionately favors the studying of 
pathologies of high-income countries.3 Leading authors 
and modern textbooks in rehabilitation medicine come 
from developed health systems.  Many advanced 
treatment options are probably not applicable to most of 
the global disability population because disability 
prevalence tends to be higher in low income countries.  In 
Pakistan, when I used to read the current textbooks of 
Rehabilitation, most of my understanding of rehab was 
imaginative, hypothetical and impractical.  I was fortunate 
to have a great mentor who directed my thoughts toward 
the broader aspect of rehabilitation i.e social reintegration 
and empowerment.  The critical issue is not how stroke is 
affecting your body and environment; it is actually how the 
environment is affecting the body and stroke.  When you 
change the environment, you can change the pattern of 
stroke-related impairments.  A successfully trained and 
independent stroke patient in the U.S may likely have to 
undergo a refresher course of rehabilitation if he were 
brought to Pakistan, and vice versa.  The manner in which 
external factors interact with the patient is relevant to 
rehabilitation, but this remains a less emphasized topic of 
teaching in rehabilitation medicine.  During our training, 
much importance is given to activities of daily living 
(ADLs).  The functional Independence Measure (FIM) is 
one of the most popular scales for functional assessment 
across settings; however, is it universally valid?  Studies 
suggest that the FIM scale has strong interrater reliability 
when used by clinicians in the United States.4 Language 
and other cultural barriers have been shown to impact 
functional assessment scales in other specialties.5 In 
Saudi Arabia and Pakistan, the majority of the population 
is Muslim and performing prayers five times a day is a 
common practice.  This requires an individual to perform 
ablution before the prayers, which involves washing 
different parts of the body from head to toe.  Though there 
are exceptions made for performing ablution during 
illness, many patients still prefer to perform this practice.  
Similarly, the toileting practices vary from culture to 
culture.  Considering that, I sensed a dire need for a 
modified functional assessment scale for my patients 
during my residency.  In today’s globalized world, 
physicians are routinely expected to have a broad 
understanding of alternative and culturally determined 
medical practices.6 Gender preferences, sexuality, and 
social norms are unique to different cultures.  For 
example, in Pakistan, regardless of the socioeconomic 
status of the patient or family, discharge disposition is 
barely a problem because of conventional strong family 
support. In contrast, the Ministry of Health Hospitals in 
Saudi Arabia continue to provide services to all admitted 
patients until their disposition is finalized.  Furthermore, it 
is estimated that between 10% and 30% of all 
hospitalizations in Saudi Arabia require a need for medical 
rehabilitation, and ineffective implementation of current 
laws have resulted in services not being rendered in the 
most efficient ways.7,8 In most rehabilitation settings, 
there are no insurance issues and few financial pressures 
involved in expediting a patient`s discharge or arranging 
equipment.  Consequently, patients get a chance to stay 
longer as inpatients and benefit accordingly.  In the U.S, 
continuity of rehabilitation care post discharge is 
exemplary, whereas in Pakistan and Saudi Arabia, the 
concept of primary care physician is lacking and 
community-based rehabilitation is still very primitive. 
During my training in the U.S, I am able to relate to the 
materials in my textbooks more closely.  Now, not only do 
I observe the latest management strategies, but I also 
practice them as well. That reminds me of the early days 
of my career in Pakistan.  There was a patient who came 
for treatment of frozen shoulder. He travelled hundreds of 
kilometers to reach a tertiary care facility with very little 
money.  Like many patients coming to our outpatient 
facility, we knew that he was there for the first and last 
time.  This is an example of socioeconomic challenges in 
the management of frozen shoulder.  Nowhere in any 
textbook would one come across any recommendations 
that would address the successful management 
guidelines in these circumstances that are common in the 
developing world.  How does one tailor patient 
management in similar situations?  What are the best 
options for a patient who would not be able to follow up 
with any clinician after his initial visit?  These are 
important questions, since the medically underserved 
suffer higher rates of disease morbidity.9 It is true that 
most guidelines are evidence-based, and evidence is 
usually collected by research.  But for practical purposes, 
resources are not adequate to meet the growing demands 
of research in developing world.
I have used the term ‘three-dimensional’ based on my 
experience in neurorehabilitation in three entirely different 
regions of the world namely Pakistan, Saudi Arabia and 
United States. These medical models represent a sample 
of three different levels of health care systems around the 
globe. i.e underdeveloped, developing and developed 
health system respectively . In fact, I intend to propose 
the idea that rehabilitation of a particular neurological 
impairment or impairment group needs to be explored 
along different geographical dimensions so that the 
diversity of global rehabilitation practices can be brought 
onto a single platform.  The most ideal platform, in my 
opinion, would be the popular textbooks of neurological 
rehabilitation.  Conferences and exchange programs 
provide a concentrated opportunity but even the largest 
conferences are attended by a limited number of 
clinicians. Their impact remains restricted to the 
attendees or to readers who follow literature updates. 
Ideas and innovations are the crux of rehabilitation 
sciences.  Many educational and health systems in the 
developing world do not have the capacity to support 
extensive research to validate potentially effective ideas.  
Hence, these ideas remain hidden from the world and 
never get a chance to reach across borders.  These 
practices may never get published even in local literature, 
and even if they do, the local readership may be negligible 
due to lack of access or interest.  Textbooks, however, 
remain a common source of reference for residents, 
supervisors and physicians in all academic settings 
globally.  Colleagues that are critical members of the 
team, such as therapists and nurses, can benefit from 
this as well, as cultural and sociopolitical differences 
among patients affects their approach to healthcare as 
well.10  At the completion of students’ training, the test of 
their knowledge and skills usually revolve around 
information contained in textbooks. 
It is deemed important to have a textbook of neuro 
rehabilitation featuring writers from all around the globe. A 
key chapter on a particular topic could be followed by brief 
addendums from experts from different regions of the 
world. The regional authorship could be classified based 
on socioeconomic and cultural similarities.  For example, 
North America, Europe, Russia and Australia could be 
grouped together, while China and culturally similar 
neighboring countries could be grouped together.  South 
America, the Middle East, Africa and South Asia could 
have separate addendums. Similarly, regions under war 
could be grouped together.  This approach would yield a 
bulk of knowledge ranging from evidence-based practices 
to regional practices. In this manner, thousands of 
trainees and specialists who rely upon rehab textbooks 
could become more knowledgeable with regard to both 
regional and international trends. This would also facilitate 
the input of regional representation on an international 
platform and promote local authorities in their respective 
fields of interest.  In this manner, we could strengthen our 
knowledge of the rehabilitation process through a 
multidimensional process.
ACKNOWLEDGEMENTS
Authors would like to thank Elizabeth T. Mumford, MA for 
reviewing and editing the manuscript.
REFERENCES
1. Bloj MG, Kersten D, Hurlbert AC. Perception of three- 
 dimensional shape influences colour perception
 through mutual illumination. Nature 1999;402: 
 877-879. 
2. Tuakli-Wosornu YA, Haig AJ. Implementing the World
 Report on Disability in West Africa: challenges and 
 opportunities for Ghana.  Am J Phys Med Rehabil 
 2014;93(1 Suppl 1):S50-57. 
3. Global Forum for Health Research. 10/90 Report on 
 Health Research 2003–2004. Geneva, Switzerland: 
 Global Forum for Health Research; 2004. 
4. Hamilton BB, Laughlin JA, Fiedler RC, Granger CV. 
 Interrater reliability of the 7-level functional 
 independence measure (FIM). Scandinavian Journal 
 of Rehabilitation Medicine 1994;26(3):115-119. 
5. D.I. Velligan, M. Rubin, M.M. Fredrick et al. The 
 cultural adaptability of intermediate measures of 
 functional outcome in schizophrenia. Schizophrenia
 Bulletin 2012;38(3):630-641. 
6. Bateman C, Baker T, Hoornenborg E, Ericsson U. 
 Bringing global issues to medical teaching. Lancet 
 2001;358:1539–1542. 
7. Al-Jadid MS. Disability in Saudi Arabia. Saudi Med J 
 2013;34:453–60. 
8. Al-Jadid MS. Disability Trends in Saudi Arabia: 
 Prevalence and Causes Am J Phys Med Rehabil 
 2014;93(1 Suppl 1):S47-49. 
9. Murray CJL, Kulkarni S, Ezzati M. Eight Americas: new 
 perspectives on U.S. health disparities. Am J Prev 
 Med 2005;29(5 suppl 1):4–10.  
10. Taff SD, Bakhshi P, Babulal GM. The 
 Accountability-Well-Being-Ethics framework: a new 
 philosophical foundation for occupational therapy. 
 Can J OccupTher 2014;81(5):320-329.
Appendix A
Epilepsy in Pakistan: Classification and Diagnosis 
Guidelines for Clinicians:
QUESTIONS ADDRESSED 
Q1-Definition of Epilepsy: Adapted from New definition of 
ILAE review statement 2104
Q2-Q5-Classification of seizures, Epilepsy and epilepsy 
syndromes and etiologic basis
Q5-Q10-Diagnosis (history, physical exam, relevant lab 
tests, EEG, Neuroimaging)
Definition of Epilepsy: 
In 2013 an international taskforce of the ILAE shaped out 
a communal definition of Epilepsy.(2) This definition is useful 
for all or most practical purposes, thus more helpful in 
management. Epilepsy was defined as recurrent 
unprovoked seizures i.e 2 or more at least 24 hours apart. 
The revised practical definition implies that Epilepsy can be 
considered even after a single seizure in individuals who 
have other factors predictive of a second unprovoked 
seizure, a risk set at 60%. The factors include the diagnosis 
of an epilepsy syndrome, structural lesions like stroke, CNS 
infections, intraparenchymal contusions after trauma, as 
well as reflex seizures such as photosensitive seizures. (3)
Table 1 (2)
A person is considered to have epilepsy if they meet any 
of the following conditions:
At least two unprovoked (or reflex) seizures occurring 
greater than 24 hours apart.
One unprovoked (or reflex) seizure and a probability of 
further seizures similar to the general recurrence risk (at 
least 60%) after two unprovoked seizures, occurring over 
the next 10 years or the diagnosis of an epilepsy 
syndrome is clear. 
The Seizure: 
A seizure is defined as a clinical manifestation of 
abnormal discharges of a group of cortical neurons. For 
the purpose of these guidelines seizures are divided into 
two main categories 
Focal/Partial and Generalized. 
Focal seizures or partial arise from a focal point in the 
brain that can be identified by history. An aura is always a 
sign of a focal seizure. Focal seizures can be simple partial 
or complex partial. Generalized seizures do not have an 
identifiable focal point and involve entire brain at the 
onset. 
Simple Partial Seizures 
• Locus
 – one site or lobe
• Manifestations
 – Duration: ~30secs
 – Involuntary muscle jerks, sensory (tastes or  
  smells), psychic or emotional (fear)
 – Foul smell, metallic taste, light-headedness,  
  bright light, rising sensation in stomach.
• Consciousness
 – Retained
Complex Partial Seizures
• Locus 
 – One or multiple sites, TLE
• Manifestations
 – Duration: 1-3 min
 – Automatisms (picking at clothes, lip smacking,  
  wandering, repeating words)
 – May begin with SPS (aura)
• Consciousness
 – loses consciousness
Generalized Seizures 
• Primary generalized
 – Locus: both hemispheres affected from outset
 – Manifestation: 
  • Duration ~2mins
  • Muscles rigid(tonic)-person falls down,  
   rhythmic muscle contractions (Clonic),  
   shallow breathing, incontinence, post  
   ictal drowsiness, and confusion
  • Usually no aura or warning
  • Consciousness is lost
• Secondarily generalized
 – Preceded by SPS or CPS
• 
• 
Neonatal Seizures
• Odd presentation
• Not follow usual classification of Partial and   
 generalized seizures
• Focality very difficult to assess
Clinical Seizure
• Subtle
• Tonic
• Clonic 
• Myoclonic
Table 2.
Table 3.
Table 4.
Seizure Types :(20)
• Simple Partial and Aura
 – Consciousness retained 
• Complesx partial 
 – Consciousness impaired 
• Secondarily generalized 
 – Seizures that begin with a focal onset like aura, or 
evolve from partial onset and progress to generalized seizure
Simple partial and complex partial with or without 
generalization are considered focal when groped into 
syndromes
• Generalized 
 – Tonic
 – Clonic
 – Tonic clonic
 – Atonic
 – Absence
  • Typical 
  • Atypical
 – Absence  with special features – Myoclonic 
absence ; Eyelid myoclonia  
 – Myoclonic
 – Myoclonic aestatic 
• Unknown Epileptic spasms
• Non epileptic Seizures
(Seizures that cant be clearly diagnosed into one of the 
preceding categories should be considered unclassified 
until further information allows for their accurate diagnosis)
EPILEPSY SYNDROMES
• Often provides information on how long the seizures 
persist and which medications can be useful and which to 
avoid. 
• Defined by a cluster of characterstics
 – seizure type
 – EEG findings
 – neurologic status
 – age at onset
 – family history 
 – prognosis
For the sake of brevity and practical applicability of these 
guidelines the syndromes are simplified in few main 
categories 
Overall three categories in adults three more in children
1. Idiopatic Generalized Epilepsy (IGE) (Juvenile myoclonic 
epilepsy, absance, GTC, tonic, atonic)
2. Symptomatic localization related epilepsy(SLRE) 
 – Temporal lobe epilepsy
 – Frontal lobe epilepsy
 – Occipital lobe epilepsies 
3. Symptomatic Generalized Epilepsy eg Lennox- Gastaut 
syndrome
4. Other Epilepsies like Febrile seizures
5. West syndrome (Infantile spasms)
6. Benign rolandic epilepsy in children
Others like Reflex epilepsies and metabolic syndromes 
A detailed list of Epilepsy syndromes is outlined in table 5. 
Table 5
EPILEPSY SYNDROMES: (21-22)
Epilepsy syndromes arranged by age at onset 
• Neonatal period 
 – Benign familial neonatal epilepsy (BFNE) 
 – Early myoclonic encephalopathy (EME) 
 – Ohtahara syndrome 
• Infancy 
 – Epilepsy of infancy with migrating focal seizures 
 – West syndrome
• Myoclonic Epilepsy in infancy (MEI) 
 
Benign infantile epilepsy 
Benign familial infantile epilepsy 
Dravet syndrome 
Myoclonic encephalopathy in nonprogressive disorders 
Panayiotopoulos syndrome 
Epilepsy with myoclonic atonic (previously astatic) seizures 
Benign epilepsy with centrotemporal spikes (BECTS) 
Autosomal-dominant nocturnal frontal lobe epilepsy 
(ADNFLE)
Late onset childhood occipital epilepsy (Gastaut type) 
Epilepsy with myoclonic absences 
Lennox-Gastaut syndrome 
Epileptic encephalopathy with continuous spike-and-wave 
during sleep (CSWS)
Landau-Kleffner syndrome (LKS) 
Childhood absence epilepsy (CAE) 
Adolescence – Adult 
Juvenile absence epilepsy (JAE) 
Juvenile myoclonic epilepsy (JME) 
Epilepsy with generalized tonic–clonic seizures alone 
Progressive myoclonus epilepsies (PME) 
Autosomal dominant epilepsy with auditory features 
(ADEAF) 
Other familial temporal lobe epilepsies 
Less specific age relationship 
Familial focal epilepsy with variable foci (childhood to 
adult) 
Reflex epilepsies 
Distinctive constellations (lesion related symptomatic)
Mesial temporal lobe epilepsy with hippocampal 
Sclerosis (MTLE with HS) 
Frontal lobe Epilepsy (FLE)
Occipital Lobe Epilepsy (OLE)
Rasmussen syndrome 
Gelastic seizures with hypothalamic hamartoma 
Hemiconvulsion–hemiplegia–epilepsy 
Epilepsies that do not fit into any of these diagnostic 
categories can be distinguished first on the basis of the 
presence or absence of a known structural or metabolic 
condition (presumed cause) and then on the basis of the 
primary mode of seizure onset (generalized vs. focal) 
Epilepsies attributed to and organized by structural- 
metabolic causes 
Malformations of cortical development (hemimegalencephaly, 
heterotopias, etc.) 
Neurocutaneous syndromes (tuberous sclerosis complex, 
Sturge-Weber, etc.) 
Tumor 
Infection 
Trauma 
Angioma 
Perinatal insults 
Stroke 
Etc. 
Epilepsies of unknown cause 
Conditions with epileptic seizures that are traditionally not 
diagnosed as a form of epilepsy per se 
Benign neonatal seizures (BNS) 
Febrile seizures (FS) (22)
Childhood 
Febrile seizures plus (FS+) (can start in infancy) 
Panayiotopoulos syndrome 
Epilepsy with myoclonic atonic (previously astatic) 
seizures 
DIAGNOSIS
Making the correct diagnosis is the key to all 
management. In PWE there are major health, educational 
and psycho-social implications. It is most important that 
the physician is sensitive to PWEs and their families when 
communicating the diagnosis of epilepsy. Epilepsy 
remains a clinical diagnosis and it can be difficult. 
Misdiagnosis is frequent about 25% of cases in developed 
countries, much higher particularly when made by non 
neurologists. This itself can cause social and financial 
losses due to the wrong label, not to mention the side 
effects of unnecessary treatment as well. Conversely 
Individuals may die because diagnosis was not made. The 
diagnosis of Epilepsy remains a clinical diagnosis with all 
tests providing supplementary data. 
History                                                            
• A detailed history should be taken from the child, 
young person or adult 
• An eyewitness to the attack, where possible, to 
determine whether or not an epileptic 
seizure is lllikely to have occurred.
• The clinical decision as to whether an epileptic 
seizure has occurred should then be based on the 
combination of the description and the different 
symptoms. 
• Diagnosis should not be based on the presence or 
absence of a single feature.
Physical Exam
PWE presenting with a seizure, a physical examination 
should be carried out. Vitals, inspection of skin, in children 
a general physical especially abdominal to r/o hepato- 
splenomegaly.
Include their cardiac, neurological and mental status and 
in case of children a developmental assessment where 
appropriate. [18] 
Follow-up should always be arranged 
Where non-epileptic attack disorder is suspected, first rule 
out organic cause then make suitable referral to 
psychological or psychiatric services for further 
investigation and treatment.
Epilepsy: Differential Diagnosis
• Many other conditions may be confused with 
epilepsy:
–  syncope - reflex, cardiac, postural
–  Psychogenic non epileptic seizures PNES
–  TIA
–  panic attacks
–  sleep disorders
–  hypo/hyperglycemia
–  migraine
–  Vertigo
– intra ventricular colloid cyst, 
– cataplexy, 
– Acute symptomatic seizure secondary to 
hypoglycemia, alcohol intake, alchohol withdrawal, 
hyponatremia, eclampsia etc.
Differentiating seizures from syncope/LOC
Questions to ask and if “yes”, support a diagnosis of 
epileptic seizure: 
•  At times do you wake up with a cut tongue after your 
spells? 
•  At times do you have a sense of déjà vu or jamais vu 
before your spells? 
•  At times is emotional stress associated with losing 
consciousness? 
•  Has anyone noticed your head turning during a spell? 
•  Has anyone ever noted that you are unresponsive, have 
unusual posturing or have jerking 
limbs during your spells or have no memory of your spells 
afterwards? 
• Has anyone noticed that you are confused after a 
spell?
• Have you had any episodes while lying down or during 
sleep? 
Questions if “yes”, support a diagnosis of syncope: 
• Have you ever had light-headed spells? 
• Are all your attacks during the erect position?
• At times do you sweat before your spells? 
Differentiating PNES with NES
Questions if “yes” support a diagnosis of PNES:
• Are all events during waking?
• Are you aware of the surroundings while you are 
unable to respond?
• Is there pelvic thrusting and bicycling that lasts for 
more usually longer than a couple of minutes. 
• Do they always occur in the presence of someone or 
during an argument?
• Do they last for hours ?
• Do they wax and wane over the span of hours with no 
stereotype?
Questions if “yes” support a diagnosis of ES: 
• Are the episodes stereotyped and brief?
• Do they occur during sleep?
• Are they associated with incontinence?
• Is there tongue bite on lateral edges of the tongue?
In Children
Breath holding spells, febrile fits, syncope, parasomnias, 
behavioral issues should be differentiated. 
Role of Home video”s and written discrptions
Prospective recording of events, including video recording 
and written descriptions, can be very 
helpful in reaching a diagnosis.
 
Investigations 
A range of investigations, chiefly EEG and brain imaging, 
are available to assist the clinician in Classifying seizures 
and epilepsy syndromes of individuals suspected as 
having epilepsy. 
Q. The role of EEG in making a diagnosis of epilepsy :
1. An EEG should be performed to support a diagnosis 
of epilepsy in PWE in whom the 
clinical history suggests that the seizure is likely to be 
epileptic in origin.  
2. The normalEEG should not be used to exclude a 
diagnosis of epilepsy in PWE in whom 
the clinical presentation supports a diagnosis of a 
non-epileptic event. 
3. The EEG should not be used in isolation to make a 
diagnosis of epilepsy. 
6. The EEG should be reported by a qualified 
neurophysiologist to minimize over/under reporting.  
These not being available arrangements for workshops 
and doubtful tracings to be sent to qualified 
neurophysiologists be made. 
7. The finding of interictal epileptiform activity on EEG 
can be used to help confirm the 
Clinical diagnosis of an epileptic seizure.  A negative EEG 
cannot be used to rule out the
clinical diagnosis of an epileptic seizure.                                                      
8. When a standard EEG has not contributed to 
diagnosis or classification, a sleep EEG should be 
performed.A sleep EEG is best achieved through sleep 
deprivation or the use of 
Melatonin
9. A routine EEG should include activation procedures 
like photic stimulation and hyperventilation if not 
contraindicated due to state and condition of the patient.
10. Chloral hydrate, clonazepam (in children) and 
midazolam, diazepam or other benzodiazepines should 
not be used to sedate the patient prior to EEG.
11. When Temporal lobe Epilepsy is in the differential 
extra anterior tempotal leads should be applied T1 and T2 
preferably
12. When occipital lobe involvement is in the differential 
or occipital discharges are noted a posterior halo or 
headband montage should be used. 
13. Longterm video EEG should be used in PWE  who 
present with diagnostic difficulties after clinical 
assessment and standard EEG is not supportive or 
questionable as well as PNES suspected cases. 
The role of neuroimaging in the diagnosis of epilepsy 
Neuroimaging should be used to identify structural 
abnormalities that cause certain epilepsies. 
It is recommended in patients with focal onset seizures or 
multifocal seizures or when there is an acute change in 
seizure semiology and frequency in a compliant previously 
controlled PWE.
1. MRI should be the imaging investigation of choice in 
children, young people and adults with epilepsy. (specified 
seizure protochol see appendix)
MRI is particularly important in those: 
• who develop epilepsy before the age of 2 years or in 
adulthood 
• who have any suggestion of a focal onset on history, 
examination or EEG (unless clear 
evidence of benign focal epilepsy) 
• in whom seizures continue in spite of first-line 
medication. 
2. Neuroimaging should not be routinely requested 
when a diagnosis of idiopathic 
generalized epilepsy has been made.
3. CT should be used to identify underlying gross 
pathology if MRI is not available or is contraindicated, and 
for children and young people  in whom a general 
anaesthetic or sedation would be required for MRI but not 
CT. The CT should be at least 64 slice scanner and thin 
cuts with axial and coronal views. 
4. In an acute situation, CT may be used to determine 
whether a seizure has been caused by an acute 
neurological lesion or illness.  
The Seizure Protocol MRI : Special Thanks to 
Dr. Zafar Sajjad, Professor, Department Of Radiology,
Aga Khan University, Karachi.
Recommendations
• MRI request should say Seizure protocol
• Though a screening protocol has been put in the end 
it is important to reiterate that screening MRIs for strokes 
and tumors on low field strength machines (becoming a 
norm through Pakistan) is a false economy for Epilepsy. 
• All MRI centers should have the protocol and guide 
the patient if they do not have the specifics. 
Protocol Considerations
1. Axial  T1 and T2  images standard SE/TSE 5mm should 
be done in all cases. 
2. Fluid inversion (FLAIR) sequences in Coronal Plane in 
all PWE
3. Gadolinium contrast enhancement increases the cost 
further and  is not necessary in routine cases but helpful 
in selected cases  In patients where sedation or GA is 
required to enable the test the cost of not doing the 
contrast scan may be higher if the entire procedure is to 
be repeated.
Patients should have at least 1 contrast enhanced scan in 
the course of their disease.
4. Coronal Flair and T2 images in all seizure protocols 
irrespective of whether contrast is given or not. If contrast 
is given post contrast coronal should also be taken. 
5. If temporal lobe epilepsy is in the differential : Coronal 
FLAIR and High Resolution, thin section T2 sequences 
perpendicular to the long axis of the hippocampus, with 
and without contrast.
6. If cortical dysplasia is suspected:  Sagittal  T1 along 
with  Axial T1, T2 FSE/TSE , Axial FLAIR  Axial DWI / ADC . 
Coronal T2,  and  3D Volume GRE – T1, thin-section, 
whole brain but  If there is a known EEG focus  then do the 
coronal thin T2 and FLAIR (from the MTS protocol) in the 
suspicious EEG location. If any abnormality noticed, then 
give contrast. NOTE: This will apply only to the paediatric/ 
adolescent population.  In this a T1 GRE volume and a T1 
IR sequence would be sufficient.  DWI is now standard of 
care on all brain MRIs and should be acquired irrespective 
of indication.
7. T1 GRE volumes and T1 IR axial slices in all patients 
below the age of 18 years.
Recommendation for a Standardized Seizure 
protocol MRI:
Should only be carried out on a high field strength (1.5T 
or above) magnet
Axial TSE T2 5mm
Axial SE T1 5 mm
Coronal  FLAIR 5mm
Coronal High Resolution T2 perpendicular to the 
hippocampus
Axial DWI min b=1000
Post contrast Axial T1 and FLAIR coronal
For the paediatric age group add:
T1 GRE volume.  Primary acquisition in the coronal plain.
T1 IR Axial or coronal
For focal seizures or secondary generalization add
SWI Axial
eople (9)
Show details
Laboratory tests
1. Measurement of serum prolactin is not 
recommended for the diagnosis of epilepsy. 
2. In adults, appropriate blood tests (for example, 
plasma electrolytes, glucose, calcium) to 
identify potential causes and/or to identify any significant 
co-morbidity should be considered.  
3. In children and young people, other investigations, 
including blood and urine biochem 
should be undertaken at the discretion of the specialist to 
exclude other diagnoses, and to 
determine an underlying cause of the epilepsy.  
4. B12, vitamin D and serum iron, Mg, Ca, LFTs and 
serum creatine kinase, complete blood count, creatinine 
should be checked especially when on AED’s. 
Cardiovascular tests as an aid to diagnosis 
 1.  A 12-lead ECG should be performed in adults over age 
30 with suspected epilepsy. 
2.  In children and young people, a 12-lead ECG should 
be considered in cases of diagnostic 
uncertainty. 
3. In cases of atypical attacks and strong possibility 0f 
syncope or any arrhythmia on EKG,  a referral to a 
cardiologist should be considered. 
 
The role of neuropsychological assessment in the 
diagnosis and management of epilepsy? 
Neuropsychological deficits are commonly associated with 
epilepsy and its treatment.  Awarenes of these problems 
may facilitate education, social integration and 
employment
1. Neuropsychological assessment should be 
considered in children, young people and adultin whom it 
is important to evaluate learning disabilities and cognitive 
dysfunction,
 particularly in regard to language and memory. 
2. when a child, young person or adult  with epilepsy is 
having educational or occupational 
difficulties 
3. when an MRI has identified abnormalities in 
cognitively important brain regions 
4. when a child, young person or adult complains of 
memory or other cognitive deficits and/or cognitive 
decline. 
 
Conclusion
The primary scope of these guidelines is to provide a 
concise practical plan which will help identify the seizure, 
and classify it in the simplest possible form. These 
guidelines hope to provide the physicians treating epilepsy 
patients with a step wise approach to the diagnosis 
patient with epilepsy. Though some of these diagnostic 
tests are expensive making the correct diagnosis at an 
initial stage of the disease can same much in long term 
cost of morbidity and polypharmacy.
A health care structure needs to be created on the 
governmental level to provide subsidized AEDs and 
diagnostic facilities.
These guidelines will be revisited and modified on 
applicability every four years. People with epilepsy remain 
at the centre of this guideline, and the need for services 
to consider the needs of each individual and their care 
givers have been focused. 
Appendix B
EPILEPSY IN CHILDREN AND NEONATES
Diagnosis: 
Making the correct diagnosis is extremely important in 
children due to long term implications like educational, 
psychosocial, intelligence quotient, development, self 
esteem and the psychological impact on their parents. 
Misdiagnosis is more common in peads than in adults, 
particularly when diagnosis is made by non specialists. 
Recognizing and classifying seizures is different in 
neonates , infants and children as does the etiology and 
management.
 
Classification:  
See Appendix A
Treatment: 
The basic principles of AED treatment in children with 
epilepsy (CWE) remain the same as in adults. CWE should 
be encouraged to participate in normal activities with their 
peers , supervised where needed depending on the type 
of activity and seizure history. Parents of CWE should be 
advised not to be over protective. 
NEONATAL SEIZURES
Diagnosis of neonatal seizures is essentially clinical and 
must be based on observation of repeated or rhithmic 
activity which is (subtle) for example orofacial twitching, 
(clonic) limb movements, jerking not stopped when held,  
autonomic disturbances, stiffening (tonic) or sustained 
posturing of limbs. Home video of events is helpful in 
diagnosis and further management of such neonates 
needs to be done under specialized care. 
Table 1: Causes of Neonatal seizures
Ideal Metabolic Evaluation should include:
•  Blood:  glucose, lytes, BUN, creatinine, lactate, 
pyruvate, ammonia, biotinidase, quantitative amino acids, 
very long chain fatty acids
• Urine:  quantitative amino acids
• CSF:  cell count, glucose, protein, pyruvate, lactate, 
quantitative amino acids, HSV PCR
Unfortunately these are very costly and some need to be 
sent abroad increasing cost.  
General Recommendations
• All neonates with seizures should be given pyridoxine 
50-100mg 
• Neonatal screening TSH, 
• lactic acid, if acidosis biotin should be given and 
acidosis corrected.
•  serum AA and urine organic acids if inborn errors 
suspected e.g. sibling history or consanguineous marriage.  
• Stabilize vital signs and  treat underlying hypotension
• Correct transient metabolic disturbances
• Phenobarbital is first line agent
• Lorazepam and Phenytoin second line 
• Valproate and Levitiracetam if myoclonic fits.
• See table for oral AEDs that can be used
• Refer to Pediatric Neurologist ASAP
Table 3. Oral AEDs that can be used in Neonatal seizures 
 
Acute Therapy of Neonatal seizures : 
If with hypoglycemia- Glucose 10%: 2ml/k IV
If no hypoglycemia- Phenobarbital:20mg/k IV
       loading dose
       If necessary : additional phenobarbital:
       5 mg/kg IV to a max of 20 mg/kg
       (omit if respiratory compromise)
        Phenytoin: 20 mg/kg, IV (1 mg/kg/min)
        Lorazepam:0.05-0.10 mg/kg, IV  
All neonates with intractable seizures should be given 
50-100mg iv pyridoxine.
FEBRILE SEIZURES or FITS (FF)
1. Fits that occur in otherwise normal infants from age 6 
months to 6years on during high fever greater than 101oF 
or 38oC. (fever not caused by meningeal or cerebral 
infection)
2. Single FF occurs in 3-5% of children. Recurrent FF 
occurs in one third of children with FF. Recurrance is 
higher if first FF within first year of life.
3. FF may be simple or complex and this helps 
prognosticate the FF. Simple is brief, generalized <1min. 
Complex FF comprise only 15% of FF, usually partial onset, 
longer >15 minutes or multiple fits in the same illness. 
These are more likely to develop epilepsy in the future. 
4. LP (lumbar puncture) should be done in children 
suspected of CNS infection 
5. Recurrent simple FF do not warrant investigation and 
need parental counseling 
6. EEG is not required in Simple FF. it should be done in 
complex FF, febrile status epilepticus. 
7. FF is never focal
8. Neuroimaging has no role in simple FF
9. FF counseling should include lowering body 
temperature, acutely acting antiepileptic drugs like 
diazepam  orClobazam 0.75mg/kg in two divided doses, 
or phenobarbitone prophylactically during fever only. 
10. Continued prophylaxix with AEDs is not recommended 
in FF. 
11. Parents need to be taught the use of rectal diazepma 
0.5mg/kg and/or buccal midazolam (0.2-0.3mg/kg) for 
acute termination of seizure if lasts longer than 2 minutes. 
12. Parents should be cautious not to let fever rise in 
such children
CHILDHOOD Specific EPILEPSY SYNDROMES: 
(pharmachologic management)
Pharmacological management of ABSENCE 
SEIZURES 
1. Ethosuximide or sodium valproate as firstline treatment 
to children, patients with
absence seizures. If there is a high risk of GTC seizures, 
offer sodium valproate first, 
unless it is unsuitable. Be aware of teratogenic risks of 
sodium valproate. NOTE: Ethosuximide is not available in 
Pakistan.
2. Lamotrigine if ethosuximide and sodium valproate are 
unsuitable, ineffective or not tolerated. 
3. If two firstline AEDs  are ineffective in patients with 
absence seizures, consider a combination of two of these 
three AEDs as adjunctive treatment: ethosuximide, 
lamotrigineor sodium valproate. Be aware of teratogenic 
risks of sodium valproate  
4. If adjunctive treatment is ineffective or not tolerated, 
discuss with, or refer to epilepsy specialist and consider 
clobazam, clonazepam, levetiracetam, topiramate,or 
zonisamide (not available in Pakistan)
5. Do not offer carbamazepine, gabapentin, oxcarbazepine, 
phenytoin, pregabalin, tiagabine or vigabatrin.
6. Avoid VPA with clonazepam in childhood absences it 
can induce absence status
Pharmacological management of myoclonic seizures 
1. Offer VPA as first-line treatment to children, with  newly 
diagnosed myoclonic seizures, 
unless it is unsuitable. 
2. Offer LEV or TPM if VPA is not suitable or patient not 
responding
(Be aware that TPM has a less favourable sideeffect 
profile than LEV and VPA) 
3. Offer LEV, VPA or TPM as adjunctive treatment to 
children, with myoclonic seizures if firstline treatments are 
ineffective or not tolerated. Be aware of teratogenic risk of 
VPA 
4. If adjunctive treatment  is ineffective or not tolerated, 
discuss with, or refer to, epilepsy specialist and consider 
clobazam,clonazepam, piracetam or zonisamide or 
steroids. 
5. Do not offer carbamazepine, gabapentin, oxcarbazepine, 
phenytoin, pregabalin, tiagabine or vigabatrin. 
 
Pharmacological management of INFANTILE SPASMS 
1. Discuss with, or refer to, a tertiary paediatric epilepsy 
specialist when an infant presents with infantile spasms. 
These children will need polytherapy.
2. Offer a steroid (prednisolone or tetracosactide or ACTH) 
or vigabatrin with VPA as first-line treatment to infants with 
infantile spasms that are not due to tuberous sclerosis. 
Carefully consider the risk-benefit  when using vigabatrin 
or steroids. 
3. Offer vigabatrin with VPA as first-line treatment to 
infants with infantile spasms due to tuberous sclerosis. If 
vigabatrin is ineffective, offer a steroid (prednisolone or 
tetracosactide Carefully consider the risk-benefit when 
using vigabatrin or steroids. 
Pharmacological management of Dravet syndrome 
1. Discuss with, or refer to, a tertiary paediatric epilepsy 
specialist when a child presents with suspected Dravet 
syndrome. 
2. Consider VPA or TPM as first-line treatment in children 
with Dravet syndrome. 
3.If first-line treatments in patients with Dravets syndrome 
are ineffective or not tolerated try clobazam or stiripentol 
(* not available in Pakistan) as adjunctive treatment. 
4. Do not offer CBZ, gabapentin, LTG, OXC, PHT, 
pregabalin, tiagabine or vigabatrin.  
Pharmacological management of LENNOX-GASTAUT 
SYNDROME 
1. Discuss with, or refer to, a tertiary paediatric/ epilepsy 
specialist when a child presents 
with suspected Lennox–Gastaut syndrome. Most require 
poly-therapy
2. Offer VPA as first-line treatment to children with 
Lennox–Gastaut syndrome.   
3. Offer LTG, TPM as adjunctive treatment if first-line 
treatment with VPA is ineffective or not 
tolerated.  
4. Other AEDs that may be considered by the tertiary 
epilepsy specialist are rufinamide and topiramate and 
polypharmacy with benzodiazepines, trial of steroids may 
also be considered. 
5. Do not offer CBZ, gabapentin, OXC, pregabalin, 
tiagabine or vigabatrin. 
Pharmacological management of BENIGN EPILEPSY 
WITH CENTROTEMPORAL 
SPIKES,(BECTS)
1. Discuss with the child, and their family whether AED 
treatment for benign epilepsy with 
Centro-temporal spikes, 
2. Offer LTG or CBZ* as first-line treatment.
3. Offer LEV, OXC*, or VPA(avoid in older girls) as 2nd line 
if above fail
(*Be aware that carbamazepine and oxcarbazepine may 
exacerbate or unmask continuous spike and wave during 
slow sleep, which may occur in some children with benign 
epilepsy with centrotemporal spikes. Be aware of 
teratogenic risks of VPA and rash with LTG.)
4. Consider adjunctive treatment if a second well-tolerated 
AED is ineffective. 
5. Offer clobazam, gabapentin, LTG, LEV, OXC, VPA, TPM, 
LCM if first-line treatments fails
Refractory childhood epilepsy syndromes adjuvant 
AEDs
Other AEDs that may be considered by the tertiary 
epilepsy specialist are eslicarbazepine 
acetate, pregabalin, tiagabine, vigabatrin, LCM, and 
zonisamide,PB, PHT, TPM,
Carefully consider the risk–benefit ratio when using 
vigabatrin due to irreversible visual field constriction in 
upto 30%  
Ketogenic diet, medical marijuana, methylprednisone, 
clobazam,  nitrazepam, clonazepam, lorazepam are also 
recommended in refractory cases. 
Note
• In children, the diagnosis and management of 
epilepsy within the first few years of life may be extremely 
challenging.  For this reason, children with suspected 
epilepsy should be referred to tertiary services early, 
because of the profound developmental, behavioural and 
psychological effects that may be associated with 
continuing seizures.  
• Behavioural or developmental regression or inability 
to identify the epilepsy syndrome requires immediate 
referral to tertiary services. 
• Children, young people and adults with specific 
syndromes such as Sturge–Weber syndrome, the 
hemispheric syndromes, Rasmussen’s encephalitis and 
hypothalamic hamartoma should be referred to a tertiary 
epilepsy service.  
• All PWE and learning disabilities should have a risk 
assessment including: 
• bathing and showering 
• preparing food 
• using electrical equipment 
• managing prolonged or serial seizures 
• the impact of epilepsy in social settings 
• SUDEP 
Annexure: RCT review and our modifications)
Partial Seizures: Children
Recommendations 
Level A: OXC
Level B: None (RTC) LTG (NICE)
Level C: CBZ, PB, PHT,TPM, VPA, VGB
Level D: LTG, ZNS, CLB, CZP
Level E: Others
Level F: None
Recomendations: PB*, VPA, CBZ, OXC, LTG, 
Generalized Tonic Clonic Seizures: Children
Recommendations
Level A: None
Level B: None
Level C: CBZ*,PB, PHT*,TPM,VPA
Level D: OXC* LEV, LTG, (considered first line NICE)
Level E: Others
Level F: None
*may aggravate tonic clonic seizures and more commonly 
other generalized seizure types, should be used with 
caution 
Women of childbearing age with epilepsy 
Introduction 
Most women with epilepsy who are receiving optimal 
treatment for their epilepsy, and who are well-informed, 
supported and fully counselled have uncomplicated 
pregnancies, normal deliveries, and healthy children. 
However in Pakistan no such proper program or 
counseling or management plan is available. Thus number 
of complications and perinatal problems are high in WWE 
(women with epilepsy). A number of issues need to be 
considered 
• Both the disease and its treatment may alter the 
menstrual cycle and fertility.  
• There are problems with drug interactions, particularly 
with hormonal contraceptives.  Some methods of 
hormonal contraception may not be as effective in women 
taking AEDS.  The effectiveness will depend on which 
AED(s) are being taken. Effective contraception has an 
additional importance in women with epilepsy because of 
the risks associated with an unplanned pregnancy to the 
women and the developing  fetus.  
• AEDs are associated with teratogenic effects.  
• Both AEDs and uncontrolled seizures can cause 
adverse effects during pregnancy.  
Conversely, pregnancy and menses can affect seizure 
control due to hormonally induced alteration of the seizure 
threshold.
• Every pregnancy is different. 
Management of Epilepsy in Women can be divided into 5 
phases: 
1. COUNSELLING
2. CONTRACEPTION
3. PREGNANCY
4. LABOUR
5. POST PARTUM AND LACTATION 
COUNSELLING 
• In order to enable informed decisions and choice, and 
to reduce misunderstandings, women  and girls with 
epilepsy and their partners, as appropriate, must be given 
accurate information and counselling about contraception, 
conception, pregnancy, caring for children and 
breastfeeding, and menopause.  
• All healthcare professionals who treat, care for, or 
support women and girls with epilepsy should be familiar 
with relevant information and the availability of counseling 
the risk of AEDs causing malformations and possible 
neurodevelopmental impairments in an unborn child.
• Assess the risks and benefits of treatment with 
individual drugs. There are limited data on risks to the 
unborn child associated with newer drugs. Specifically 
discuss the risk of continued use of sodium valproate to 
the unbornchild, being aware that higher doses of sodium 
valproate (more than 800 mg/day) and polytherapy, 
particularly with sodium valproate, are associated with 
greater risk. (see table drugs and teratogenicity)
CONTRACEPTION
1. CBZ, PHT, OXC, TPM and barbiturates reduce the 
effectiveness of oral contraceptives
 necessitating the use of alternative methods, or special 
highdose regimens of oral contraceptives.  Even with this 
precaution, the effectiveness of the oral contraceptive is 
reduced.  (Ia NICE) 
2. Hormone-releasing IUDs are effective as a method of 
contraception in women taking AEDs. 
3. There is limited evidence that progesterone implants 
(specifically levonorgestrel) are ineffective
 in women taking enzyme-inducing AEDs. 
4. Progesterone pill should be avoided. 
5. There is no evidence on the effectiveness of emergency 
contraception in women taking enzyme-
inducing AEDs. 
6. There needs to be a National Pregnancy registry.
PREGNANCY
7. AED’s should be continued in pregnancy. There is no 
benefit of stopping AED’s after 3-4 weeks of conception 
(nural tube formed), and risk of seizures outweighs risk of 
continued AED exposure in vitro. 
Table 12: AED’s and Pregnancy Risk: 
8. When should screening for structural fetal anomalies 
be performed in pregnant women 
with epilepsy? 
A recent NICE guideline reviewed the evidence on the 
detection of structural fetal abnormalities in healthy 
pregnant women.
It is recommended that ‘pregnant women should be 
offered an ultrasound scan to screen for structural 
anomalies, ideally between 18 to 20 weeks of gestation, 
by an appropriately trained sonographer and with  
equipment of an appropriate standard.
9. When should folic acid be started? 
• All women nd girls on AEDs should be offered 5mg
per day of folic acid before any possibility of pregnancy.  
• There is limited evidence to show that folic acid 
supplementation reduces the risk of
• Neural tube defects and other congenital 
malformations in women taking AEDs.   
• Women who are planning pregnancy should be 
advised to take 400mcg of folic acid from when they 
begin trying to conceive until the 12th week of pregnancy 
and that those who suspect they are pregnant and who 
have not been taking supplements should start folic acid 
supplements 5mg immediately and continue until the 
12th week of pregnancy.
10. Serum levels of AEDs are of help during pregnancy. 
The dose of AEDs should not be increased routinely if 
levels are low except if seizures start occurring, and at the 
time of delivery to avoid breakthrough seizures during the 
stress of labour. 
11. If preterm labor is threatened in women taking 
enzyme-inducing AEDs, 48mg betamethasone (double 
the normal dose) should be given over 48 hours. 
12. Vitamin K 10mg i.m. at 34 and 36 weeks is 
recommended for all women unless there is a 
contraindication. 
13. Some counseling points: 
What are the dangers of seizures in women who are 
pregnant or post-natal? 
• Women and girls with epilepsy need accurate 
information during pregnancy, and the possibility of status 
epilepticus and SUDEP should be discussed with all 
women and girls who plan to stop AED therapy 
• Women and girls with generalised tonicclonic seizures 
should be informed that the fetus may be at relatively 
higher risk of harm during a seizure, although the absolute 
risk remains very low, and the level of risk may depend on 
seizure frequency. 
• There is no evidence that simple focal, complex focal, 
absence and myoclonic seizures adversely affect the 
pregnancy or developing fetus.  
• Generalized tonicclonic seizures are likely to result in 
more profound hypoxia than in the nongravid state due to 
increased maternal oxygen requirements.  This may have 
adverse affects for the fetus
POST-CONCEPTION
14. Counselling about safety during child rearing, like to 
keep baby in a crib next to the bed, care to avoid dropping 
the baby especially JME.
15. Breast Feeding guide: All mothers should be 
encouraged to breast feed. 
16. The doseage of AEDs such as LTG, LEV, OXC may have 
to be reduced if they were raised during pregnancy but 
after 6 weeks post partum 
17. Spacing between pregnancies should be 
recommended and safe/ effective contraceptive methods 
should be offered to all WWE. 
MANAGEMENT OF STATUS EPILEPTICUS Guidelines 
for Pakistan:
When a convulsive seizure continues for a prolonged 
period (longer than 5 minutes), or when convulsive 
seizures occur one after the other with no recovery in 
between patient is considered to be in Status Epilepticus. 
Convulsive status epilepticus is an emergency and 
requires immediate medical attention. TREAT HARD and 
TREAT FAST 
APPENDIX : STATUS EPILEPTICUS PROTOCOL
Definition:  
1. Convulsive Status Epilepticus (CSE): in adults and 
children older than 5 years is characterized by continuous 
convulsive seizures lasting more than 5 minutes or two or 
more seizures in 20 minutes without gaining 
consciousness in between.
2. Non-convulsive status epilepticus (NCSE) is mental 
status changes from baseline for at least 30 minutes 
associated with ictal discharges on EEG. It should be 
suspected in patient after convulsive seizure who is not 
regaining consciousness. 
3. Refractory Status Epilepticus: (RSE) Seizure activity 
that continues after first and second line AED therapy 
have failed. This can be CSE and NCSE.
MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS:
PRE-HOSPITAL STAGE: FIRST 5-10 MINUTES
• Children: Rectal diazepam 0.5mg /kg or buccal 
midazolam 0.2-0.3mg/kg ; adults: rectal diazepam 10mg 
or buccal midazolam 10mg (home)
• Maintain iv line as soon as possible and administer 
5-10mg diazepam or 3-5 mg midazolam iv push followed 
by saline flush. (EMS)
• Secure airway, breathing and circulation
HOSPITAL STAGE: 5-20 MINUTES
• Diazepam 0.2mg /kg (maximum 10mg) over 
1minute,OR midazolam 0.2mg/kg ivp or im, upto 10mg;  
wait 5 minutes for seizures to terminate. Order and 
prepare IV phenytoin. If seizure terminates investigate 
cause of seizures further, if not repeat again .in children 
<2years give neurobioniv to replace thiamine and biotin. 
• Give Oxygen, stabilize airway, respitation and 
hemdynamic parameters, apply pulse oxymetry.
• Send RBS, LFT, renal functions, electrolytes, BUN, and 
CT scan. LP and CSF analysis if CNS infection suspected.
• Start PHT infusion 15-20mg/kg at maximum rate of 
50mg/min (1mg/kg/min in small children) AVOID dilution in 
glucose solution. Monitor heart rate and blood pressure, 
contraindicated in patients with heart block or hypotention 
SBP<95. (phosphenytoin 15-18mg PE/kg/min at max rate 
of 150mg PE/min is internationally the drug of choice but 
unfortunately not available in Pakistan)
HOSPITAL STAGE : ESTABLISHED GSCE 20-60minutes: 
• If seizures continue 5-10 mins after PHT, reload 
5-10mg/kg iv at same rates as above
• Seizures continue give Sodium Valproate 
25-35mg/kg at a rate of 6mg/kg/hr
• Arrange for intubation, anaesthesia on board
• Seizures continue give iv levitiracetam  loading 
1000-3000mg (adults) at 2-5mg/kg/min
• Seizures continue next stage RCE.
• Start phenobarbitone50-100mg/min IV loading dose, 
and if intubated can start infusion 0.5-5mg/kg/hr or skip 
to next stage RCE
HOSPITAL STAGE: Refractory Status Epilepticus 
(more than 60 mins)
• Prepare to intubate and transfer to ICU
• Start lacosamide 200-400mg IV 200 mg over 15 
mins (adults only)
• Ideally obtain central venous access and contiuous 
hemodynamic monitoring through arterial line and EEG 
monitoring
• Anaesthetic agents: Adults and children midazolam 
0.2mg/kg IV bolus followed by 0.1-0.4mg/kg/hour 
continuous iv infusion OR propofol 2-5mg/kg IV bolus 
followed by 5-10mg/kg/hr iv infusion OR thiopental 
10-20mg/kg IV bolus followed by 0.5-1mg/kg/hr IV infusion 
till EEG shows burst suppression (pharmacologic coma)
• Continue coma phase  for 12 hours after last seizure
• Weaning phase: reduce infusion of anaesthetic agent 
every 3 hours with EEG monitoring, if seizures recur 
re-institute coma with the same anaesthetic to the dose 
where seizures were responsive. 
• Add topiramate 200 mg bolus and 100 mg tid. 
• Identify and treat medical complications correct 
acidosis if pH 7.2 or if symptomatic in the form of cardiac 
disturbances. Vigorously treat infections, avoid penicillin 
and quinolone group of antibiotics. 
• If seizures continue and autoimmune or idiosyncratic 
modulation is suspected consider puse steroids and ivIG. 
POST STATUS PHASE
• Maintenance therapy, all AEDs that were used to 
treat the status should be continued on maintainance 
dosage till patient remains seizure free for at least 3-7 
days if patient awake, if GCS remains low gradually 
remove under EEG coverage.
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The term three-dimensional, or 3-D, usually refers to an 
object’s existing along three different axes that intersect 
at specific angles.  The three axes, or dimensions, 
represent height, width and depth and determine the 
orientation and direction of an object in space.  Increasing 
the number of dimensions of an object from one or two to 
three greatly increases our perception and understanding 
of the object.  This even impacts our perception of 
characteristics of the object, such as color, that we may 
not suspect were related.1 Consider, then, the possibility 
of extending this “holistic” model to the rehabilitation 
process of patients with neurological disabilities. Could 
impairment categories such as stroke, brain injury or 
spinal cord injury be considered three dimensional? Yes, 
we might actually view and more fully understand any 
neurological impairment by exploring its multiple 
dimensions in different health systems around the globe. 
Recently, disability issues have taken on an increasingly 
prominent role on international stages.2 I started off my 
externship in Physical Medicine and Rehabilitation at 
Mayo Hospital Lahore Pakistan and joined the same 
department as a resident trainee. After spending a total of 
9 months there I was selected to continue to my 
residency training at King Fahad Medical City where I 
spent 4 years. Subsequently I did a one year Fellowship in 
Neurorehabilitation at Wake Forest Baptist Medical Center  
North Carolina followed by another one year Fellowship in 
Interventional Rehabilitation at the same institute. I did 
not realize until recently that I have started to analyze 
impairment groups from three different perspectives 
based on my observations and experiences in different 
parts of the world. I have observed that not only disability 
arising from a neurological illness manifests differently in 
different  cultures, but also the rehabilitation strategies 
tend to vary differently in various regions of the globe for 
the exact same pathology. This goes way beyond what we 
find in our textbooks. Imagine an object in 3-dimensional 
space and make a note of its surroundings.  Now place 
that imaginary object in an entirely different location.  The 
object itself has not changed, but the background, 
brightness, colors, orientation and aura have changed.  
Does this also change your our perception towards that 
object?  It likely does.  Similarly, the pathophysiology of 
stroke remains unchanged  globally, but it has a 
completely different outlook in different regions of the 
world.  The perception of stroke rehabilitation then 
changes dramatically when you travel across continents.  
Across many fields of medicine, money poured into 
research disproportionately favors the studying of 
pathologies of high-income countries.3 Leading authors 
and modern textbooks in rehabilitation medicine come 
from developed health systems.  Many advanced 
treatment options are probably not applicable to most of 
the global disability population because disability 
prevalence tends to be higher in low income countries.  In 
Pakistan, when I used to read the current textbooks of 
Rehabilitation, most of my understanding of rehab was 
imaginative, hypothetical and impractical.  I was fortunate 
to have a great mentor who directed my thoughts toward 
the broader aspect of rehabilitation i.e social reintegration 
and empowerment.  The critical issue is not how stroke is 
affecting your body and environment; it is actually how the 
environment is affecting the body and stroke.  When you 
change the environment, you can change the pattern of 
stroke-related impairments.  A successfully trained and 
independent stroke patient in the U.S may likely have to 
undergo a refresher course of rehabilitation if he were 
brought to Pakistan, and vice versa.  The manner in which 
external factors interact with the patient is relevant to 
rehabilitation, but this remains a less emphasized topic of 
teaching in rehabilitation medicine.  During our training, 
much importance is given to activities of daily living 
(ADLs).  The functional Independence Measure (FIM) is 
one of the most popular scales for functional assessment 
across settings; however, is it universally valid?  Studies 
suggest that the FIM scale has strong interrater reliability 
when used by clinicians in the United States.4 Language 
and other cultural barriers have been shown to impact 
functional assessment scales in other specialties.5 In 
Saudi Arabia and Pakistan, the majority of the population 
is Muslim and performing prayers five times a day is a 
common practice.  This requires an individual to perform 
ablution before the prayers, which involves washing 
different parts of the body from head to toe.  Though there 
are exceptions made for performing ablution during 
illness, many patients still prefer to perform this practice.  
Similarly, the toileting practices vary from culture to 
culture.  Considering that, I sensed a dire need for a 
modified functional assessment scale for my patients 
during my residency.  In today’s globalized world, 
physicians are routinely expected to have a broad 
understanding of alternative and culturally determined 
medical practices.6 Gender preferences, sexuality, and 
social norms are unique to different cultures.  For 
example, in Pakistan, regardless of the socioeconomic 
status of the patient or family, discharge disposition is 
barely a problem because of conventional strong family 
support. In contrast, the Ministry of Health Hospitals in 
Saudi Arabia continue to provide services to all admitted 
patients until their disposition is finalized.  Furthermore, it 
is estimated that between 10% and 30% of all 
hospitalizations in Saudi Arabia require a need for medical 
rehabilitation, and ineffective implementation of current 
laws have resulted in services not being rendered in the 
most efficient ways.7,8 In most rehabilitation settings, 
there are no insurance issues and few financial pressures 
involved in expediting a patient`s discharge or arranging 
equipment.  Consequently, patients get a chance to stay 
longer as inpatients and benefit accordingly.  In the U.S, 
continuity of rehabilitation care post discharge is 
exemplary, whereas in Pakistan and Saudi Arabia, the 
concept of primary care physician is lacking and 
community-based rehabilitation is still very primitive. 
During my training in the U.S, I am able to relate to the 
materials in my textbooks more closely.  Now, not only do 
I observe the latest management strategies, but I also 
practice them as well. That reminds me of the early days 
of my career in Pakistan.  There was a patient who came 
for treatment of frozen shoulder. He travelled hundreds of 
kilometers to reach a tertiary care facility with very little 
money.  Like many patients coming to our outpatient 
facility, we knew that he was there for the first and last 
time.  This is an example of socioeconomic challenges in 
the management of frozen shoulder.  Nowhere in any 
textbook would one come across any recommendations 
that would address the successful management 
guidelines in these circumstances that are common in the 
developing world.  How does one tailor patient 
management in similar situations?  What are the best 
options for a patient who would not be able to follow up 
with any clinician after his initial visit?  These are 
important questions, since the medically underserved 
suffer higher rates of disease morbidity.9 It is true that 
most guidelines are evidence-based, and evidence is 
usually collected by research.  But for practical purposes, 
resources are not adequate to meet the growing demands 
of research in developing world.
I have used the term ‘three-dimensional’ based on my 
experience in neurorehabilitation in three entirely different 
regions of the world namely Pakistan, Saudi Arabia and 
United States. These medical models represent a sample 
of three different levels of health care systems around the 
globe. i.e underdeveloped, developing and developed 
health system respectively . In fact, I intend to propose 
the idea that rehabilitation of a particular neurological 
impairment or impairment group needs to be explored 
along different geographical dimensions so that the 
diversity of global rehabilitation practices can be brought 
onto a single platform.  The most ideal platform, in my 
opinion, would be the popular textbooks of neurological 
rehabilitation.  Conferences and exchange programs 
provide a concentrated opportunity but even the largest 
conferences are attended by a limited number of 
clinicians. Their impact remains restricted to the 
attendees or to readers who follow literature updates. 
Ideas and innovations are the crux of rehabilitation 
sciences.  Many educational and health systems in the 
developing world do not have the capacity to support 
extensive research to validate potentially effective ideas.  
Hence, these ideas remain hidden from the world and 
never get a chance to reach across borders.  These 
practices may never get published even in local literature, 
and even if they do, the local readership may be negligible 
due to lack of access or interest.  Textbooks, however, 
remain a common source of reference for residents, 
supervisors and physicians in all academic settings 
globally.  Colleagues that are critical members of the 
team, such as therapists and nurses, can benefit from 
this as well, as cultural and sociopolitical differences 
among patients affects their approach to healthcare as 
well.10  At the completion of students’ training, the test of 
their knowledge and skills usually revolve around 
information contained in textbooks. 
It is deemed important to have a textbook of neuro 
rehabilitation featuring writers from all around the globe. A 
key chapter on a particular topic could be followed by brief 
addendums from experts from different regions of the 
world. The regional authorship could be classified based 
on socioeconomic and cultural similarities.  For example, 
North America, Europe, Russia and Australia could be 
grouped together, while China and culturally similar 
neighboring countries could be grouped together.  South 
America, the Middle East, Africa and South Asia could 
have separate addendums. Similarly, regions under war 
could be grouped together.  This approach would yield a 
bulk of knowledge ranging from evidence-based practices 
to regional practices. In this manner, thousands of 
trainees and specialists who rely upon rehab textbooks 
could become more knowledgeable with regard to both 
regional and international trends. This would also facilitate 
the input of regional representation on an international 
platform and promote local authorities in their respective 
fields of interest.  In this manner, we could strengthen our 
knowledge of the rehabilitation process through a 
multidimensional process.
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Appendix A
Epilepsy in Pakistan: Classification and Diagnosis 
Guidelines for Clinicians:
QUESTIONS ADDRESSED 
Q1-Definition of Epilepsy: Adapted from New definition of 
ILAE review statement 2104
Q2-Q5-Classification of seizures, Epilepsy and epilepsy 
syndromes and etiologic basis
Q5-Q10-Diagnosis (history, physical exam, relevant lab 
tests, EEG, Neuroimaging)
Definition of Epilepsy: 
In 2013 an international taskforce of the ILAE shaped out 
a communal definition of Epilepsy.(2) This definition is useful 
for all or most practical purposes, thus more helpful in 
management. Epilepsy was defined as recurrent 
unprovoked seizures i.e 2 or more at least 24 hours apart. 
The revised practical definition implies that Epilepsy can be 
considered even after a single seizure in individuals who 
have other factors predictive of a second unprovoked 
seizure, a risk set at 60%. The factors include the diagnosis 
of an epilepsy syndrome, structural lesions like stroke, CNS 
infections, intraparenchymal contusions after trauma, as 
well as reflex seizures such as photosensitive seizures. (3)
Table 1 (2)
A person is considered to have epilepsy if they meet any 
of the following conditions:
At least two unprovoked (or reflex) seizures occurring 
greater than 24 hours apart.
One unprovoked (or reflex) seizure and a probability of 
further seizures similar to the general recurrence risk (at 
least 60%) after two unprovoked seizures, occurring over 
the next 10 years or the diagnosis of an epilepsy 
syndrome is clear. 
The Seizure: 
A seizure is defined as a clinical manifestation of 
abnormal discharges of a group of cortical neurons. For 
the purpose of these guidelines seizures are divided into 
two main categories 
Focal/Partial and Generalized. 
Focal seizures or partial arise from a focal point in the 
brain that can be identified by history. An aura is always a 
sign of a focal seizure. Focal seizures can be simple partial 
or complex partial. Generalized seizures do not have an 
identifiable focal point and involve entire brain at the 
onset. 
Simple Partial Seizures 
• Locus
 – one site or lobe
• Manifestations
 – Duration: ~30secs
 – Involuntary muscle jerks, sensory (tastes or  
  smells), psychic or emotional (fear)
 – Foul smell, metallic taste, light-headedness,  
  bright light, rising sensation in stomach.
• Consciousness
 – Retained
Complex Partial Seizures
• Locus 
 – One or multiple sites, TLE
• Manifestations
 – Duration: 1-3 min
 – Automatisms (picking at clothes, lip smacking,  
  wandering, repeating words)
 – May begin with SPS (aura)
• Consciousness
 – loses consciousness
Generalized Seizures 
• Primary generalized
 – Locus: both hemispheres affected from outset
 – Manifestation: 
  • Duration ~2mins
  • Muscles rigid(tonic)-person falls down,  
   rhythmic muscle contractions (Clonic),  
   shallow breathing, incontinence, post  
   ictal drowsiness, and confusion
  • Usually no aura or warning
  • Consciousness is lost
• Secondarily generalized
 – Preceded by SPS or CPS
• 
• 
Neonatal Seizures
• Odd presentation
• Not follow usual classification of Partial and   
 generalized seizures
• Focality very difficult to assess
Clinical Seizure
• Subtle
• Tonic
• Clonic 
• Myoclonic
Table 2.
Table 3.
Table 4.
Seizure Types :(20)
• Simple Partial and Aura
 – Consciousness retained 
• Complesx partial 
 – Consciousness impaired 
• Secondarily generalized 
 – Seizures that begin with a focal onset like aura, or 
evolve from partial onset and progress to generalized seizure
Simple partial and complex partial with or without 
generalization are considered focal when groped into 
syndromes
• Generalized 
 – Tonic
 – Clonic
 – Tonic clonic
 – Atonic
 – Absence
  • Typical 
  • Atypical
 – Absence  with special features – Myoclonic 
absence ; Eyelid myoclonia  
 – Myoclonic
 – Myoclonic aestatic 
• Unknown Epileptic spasms
• Non epileptic Seizures
(Seizures that cant be clearly diagnosed into one of the 
preceding categories should be considered unclassified 
until further information allows for their accurate diagnosis)
EPILEPSY SYNDROMES
• Often provides information on how long the seizures 
persist and which medications can be useful and which to 
avoid. 
• Defined by a cluster of characterstics
 – seizure type
 – EEG findings
 – neurologic status
 – age at onset
 – family history 
 – prognosis
For the sake of brevity and practical applicability of these 
guidelines the syndromes are simplified in few main 
categories 
Overall three categories in adults three more in children
1. Idiopatic Generalized Epilepsy (IGE) (Juvenile myoclonic 
epilepsy, absance, GTC, tonic, atonic)
2. Symptomatic localization related epilepsy(SLRE) 
 – Temporal lobe epilepsy
 – Frontal lobe epilepsy
 – Occipital lobe epilepsies 
3. Symptomatic Generalized Epilepsy eg Lennox- Gastaut 
syndrome
4. Other Epilepsies like Febrile seizures
5. West syndrome (Infantile spasms)
6. Benign rolandic epilepsy in children
Others like Reflex epilepsies and metabolic syndromes 
A detailed list of Epilepsy syndromes is outlined in table 5. 
Table 5
EPILEPSY SYNDROMES: (21-22)
Epilepsy syndromes arranged by age at onset 
• Neonatal period 
 – Benign familial neonatal epilepsy (BFNE) 
 – Early myoclonic encephalopathy (EME) 
 – Ohtahara syndrome 
• Infancy 
 – Epilepsy of infancy with migrating focal seizures 
 – West syndrome
• Myoclonic Epilepsy in infancy (MEI) 
 
Benign infantile epilepsy 
Benign familial infantile epilepsy 
Dravet syndrome 
Myoclonic encephalopathy in nonprogressive disorders 
Panayiotopoulos syndrome 
Epilepsy with myoclonic atonic (previously astatic) seizures 
Benign epilepsy with centrotemporal spikes (BECTS) 
Autosomal-dominant nocturnal frontal lobe epilepsy 
(ADNFLE)
Late onset childhood occipital epilepsy (Gastaut type) 
Epilepsy with myoclonic absences 
Lennox-Gastaut syndrome 
Epileptic encephalopathy with continuous spike-and-wave 
during sleep (CSWS)
Landau-Kleffner syndrome (LKS) 
Childhood absence epilepsy (CAE) 
Adolescence – Adult 
Juvenile absence epilepsy (JAE) 
Juvenile myoclonic epilepsy (JME) 
Epilepsy with generalized tonic–clonic seizures alone 
Progressive myoclonus epilepsies (PME) 
Autosomal dominant epilepsy with auditory features 
(ADEAF) 
Other familial temporal lobe epilepsies 
Less specific age relationship 
Familial focal epilepsy with variable foci (childhood to 
adult) 
Reflex epilepsies 
Distinctive constellations (lesion related symptomatic)
Mesial temporal lobe epilepsy with hippocampal 
Sclerosis (MTLE with HS) 
Frontal lobe Epilepsy (FLE)
Occipital Lobe Epilepsy (OLE)
Rasmussen syndrome 
Gelastic seizures with hypothalamic hamartoma 
Hemiconvulsion–hemiplegia–epilepsy 
Epilepsies that do not fit into any of these diagnostic 
categories can be distinguished first on the basis of the 
presence or absence of a known structural or metabolic 
condition (presumed cause) and then on the basis of the 
primary mode of seizure onset (generalized vs. focal) 
Epilepsies attributed to and organized by structural- 
metabolic causes 
Malformations of cortical development (hemimegalencephaly, 
heterotopias, etc.) 
Neurocutaneous syndromes (tuberous sclerosis complex, 
Sturge-Weber, etc.) 
Tumor 
Infection 
Trauma 
Angioma 
Perinatal insults 
Stroke 
Etc. 
Epilepsies of unknown cause 
Conditions with epileptic seizures that are traditionally not 
diagnosed as a form of epilepsy per se 
Benign neonatal seizures (BNS) 
Febrile seizures (FS) (22)
Childhood 
Febrile seizures plus (FS+) (can start in infancy) 
Panayiotopoulos syndrome 
Epilepsy with myoclonic atonic (previously astatic) 
seizures 
DIAGNOSIS
Making the correct diagnosis is the key to all 
management. In PWE there are major health, educational 
and psycho-social implications. It is most important that 
the physician is sensitive to PWEs and their families when 
communicating the diagnosis of epilepsy. Epilepsy 
remains a clinical diagnosis and it can be difficult. 
Misdiagnosis is frequent about 25% of cases in developed 
countries, much higher particularly when made by non 
neurologists. This itself can cause social and financial 
losses due to the wrong label, not to mention the side 
effects of unnecessary treatment as well. Conversely 
Individuals may die because diagnosis was not made. The 
diagnosis of Epilepsy remains a clinical diagnosis with all 
tests providing supplementary data. 
History                                                            
• A detailed history should be taken from the child, 
young person or adult 
• An eyewitness to the attack, where possible, to 
determine whether or not an epileptic 
seizure is lllikely to have occurred.
• The clinical decision as to whether an epileptic 
seizure has occurred should then be based on the 
combination of the description and the different 
symptoms. 
• Diagnosis should not be based on the presence or 
absence of a single feature.
Physical Exam
PWE presenting with a seizure, a physical examination 
should be carried out. Vitals, inspection of skin, in children 
a general physical especially abdominal to r/o hepato- 
splenomegaly.
Include their cardiac, neurological and mental status and 
in case of children a developmental assessment where 
appropriate. [18] 
Follow-up should always be arranged 
Where non-epileptic attack disorder is suspected, first rule 
out organic cause then make suitable referral to 
psychological or psychiatric services for further 
investigation and treatment.
Epilepsy: Differential Diagnosis
• Many other conditions may be confused with 
epilepsy:
–  syncope - reflex, cardiac, postural
–  Psychogenic non epileptic seizures PNES
–  TIA
–  panic attacks
–  sleep disorders
–  hypo/hyperglycemia
–  migraine
–  Vertigo
– intra ventricular colloid cyst, 
– cataplexy, 
– Acute symptomatic seizure secondary to 
hypoglycemia, alcohol intake, alchohol withdrawal, 
hyponatremia, eclampsia etc.
Differentiating seizures from syncope/LOC
Questions to ask and if “yes”, support a diagnosis of 
epileptic seizure: 
•  At times do you wake up with a cut tongue after your 
spells? 
•  At times do you have a sense of déjà vu or jamais vu 
before your spells? 
•  At times is emotional stress associated with losing 
consciousness? 
•  Has anyone noticed your head turning during a spell? 
•  Has anyone ever noted that you are unresponsive, have 
unusual posturing or have jerking 
limbs during your spells or have no memory of your spells 
afterwards? 
• Has anyone noticed that you are confused after a 
spell?
• Have you had any episodes while lying down or during 
sleep? 
Questions if “yes”, support a diagnosis of syncope: 
• Have you ever had light-headed spells? 
• Are all your attacks during the erect position?
• At times do you sweat before your spells? 
Differentiating PNES with NES
Questions if “yes” support a diagnosis of PNES:
• Are all events during waking?
• Are you aware of the surroundings while you are 
unable to respond?
• Is there pelvic thrusting and bicycling that lasts for 
more usually longer than a couple of minutes. 
• Do they always occur in the presence of someone or 
during an argument?
• Do they last for hours ?
• Do they wax and wane over the span of hours with no 
stereotype?
Questions if “yes” support a diagnosis of ES: 
• Are the episodes stereotyped and brief?
• Do they occur during sleep?
• Are they associated with incontinence?
• Is there tongue bite on lateral edges of the tongue?
In Children
Breath holding spells, febrile fits, syncope, parasomnias, 
behavioral issues should be differentiated. 
Role of Home video”s and written discrptions
Prospective recording of events, including video recording 
and written descriptions, can be very 
helpful in reaching a diagnosis.
 
Investigations 
A range of investigations, chiefly EEG and brain imaging, 
are available to assist the clinician in Classifying seizures 
and epilepsy syndromes of individuals suspected as 
having epilepsy. 
Q. The role of EEG in making a diagnosis of epilepsy :
1. An EEG should be performed to support a diagnosis 
of epilepsy in PWE in whom the 
clinical history suggests that the seizure is likely to be 
epileptic in origin.  
2. The normalEEG should not be used to exclude a 
diagnosis of epilepsy in PWE in whom 
the clinical presentation supports a diagnosis of a 
non-epileptic event. 
3. The EEG should not be used in isolation to make a 
diagnosis of epilepsy. 
6. The EEG should be reported by a qualified 
neurophysiologist to minimize over/under reporting.  
These not being available arrangements for workshops 
and doubtful tracings to be sent to qualified 
neurophysiologists be made. 
7. The finding of interictal epileptiform activity on EEG 
can be used to help confirm the 
Clinical diagnosis of an epileptic seizure.  A negative EEG 
cannot be used to rule out the
clinical diagnosis of an epileptic seizure.                                                      
8. When a standard EEG has not contributed to 
diagnosis or classification, a sleep EEG should be 
performed.A sleep EEG is best achieved through sleep 
deprivation or the use of 
Melatonin
9. A routine EEG should include activation procedures 
like photic stimulation and hyperventilation if not 
contraindicated due to state and condition of the patient.
10. Chloral hydrate, clonazepam (in children) and 
midazolam, diazepam or other benzodiazepines should 
not be used to sedate the patient prior to EEG.
11. When Temporal lobe Epilepsy is in the differential 
extra anterior tempotal leads should be applied T1 and T2 
preferably
12. When occipital lobe involvement is in the differential 
or occipital discharges are noted a posterior halo or 
headband montage should be used. 
13. Longterm video EEG should be used in PWE  who 
present with diagnostic difficulties after clinical 
assessment and standard EEG is not supportive or 
questionable as well as PNES suspected cases. 
The role of neuroimaging in the diagnosis of epilepsy 
Neuroimaging should be used to identify structural 
abnormalities that cause certain epilepsies. 
It is recommended in patients with focal onset seizures or 
multifocal seizures or when there is an acute change in 
seizure semiology and frequency in a compliant previously 
controlled PWE.
1. MRI should be the imaging investigation of choice in 
children, young people and adults with epilepsy. (specified 
seizure protochol see appendix)
MRI is particularly important in those: 
• who develop epilepsy before the age of 2 years or in 
adulthood 
• who have any suggestion of a focal onset on history, 
examination or EEG (unless clear 
evidence of benign focal epilepsy) 
• in whom seizures continue in spite of first-line 
medication. 
2. Neuroimaging should not be routinely requested 
when a diagnosis of idiopathic 
generalized epilepsy has been made.
3. CT should be used to identify underlying gross 
pathology if MRI is not available or is contraindicated, and 
for children and young people  in whom a general 
anaesthetic or sedation would be required for MRI but not 
CT. The CT should be at least 64 slice scanner and thin 
cuts with axial and coronal views. 
4. In an acute situation, CT may be used to determine 
whether a seizure has been caused by an acute 
neurological lesion or illness.  
The Seizure Protocol MRI : Special Thanks to 
Dr. Zafar Sajjad, Professor, Department Of Radiology,
Aga Khan University, Karachi.
Recommendations
• MRI request should say Seizure protocol
• Though a screening protocol has been put in the end 
it is important to reiterate that screening MRIs for strokes 
and tumors on low field strength machines (becoming a 
norm through Pakistan) is a false economy for Epilepsy. 
• All MRI centers should have the protocol and guide 
the patient if they do not have the specifics. 
Protocol Considerations
1. Axial  T1 and T2  images standard SE/TSE 5mm should 
be done in all cases. 
2. Fluid inversion (FLAIR) sequences in Coronal Plane in 
all PWE
3. Gadolinium contrast enhancement increases the cost 
further and  is not necessary in routine cases but helpful 
in selected cases  In patients where sedation or GA is 
required to enable the test the cost of not doing the 
contrast scan may be higher if the entire procedure is to 
be repeated.
Patients should have at least 1 contrast enhanced scan in 
the course of their disease.
4. Coronal Flair and T2 images in all seizure protocols 
irrespective of whether contrast is given or not. If contrast 
is given post contrast coronal should also be taken. 
5. If temporal lobe epilepsy is in the differential : Coronal 
FLAIR and High Resolution, thin section T2 sequences 
perpendicular to the long axis of the hippocampus, with 
and without contrast.
6. If cortical dysplasia is suspected:  Sagittal  T1 along 
with  Axial T1, T2 FSE/TSE , Axial FLAIR  Axial DWI / ADC . 
Coronal T2,  and  3D Volume GRE – T1, thin-section, 
whole brain but  If there is a known EEG focus  then do the 
coronal thin T2 and FLAIR (from the MTS protocol) in the 
suspicious EEG location. If any abnormality noticed, then 
give contrast. NOTE: This will apply only to the paediatric/ 
adolescent population.  In this a T1 GRE volume and a T1 
IR sequence would be sufficient.  DWI is now standard of 
care on all brain MRIs and should be acquired irrespective 
of indication.
7. T1 GRE volumes and T1 IR axial slices in all patients 
below the age of 18 years.
Recommendation for a Standardized Seizure 
protocol MRI:
Should only be carried out on a high field strength (1.5T 
or above) magnet
Axial TSE T2 5mm
Axial SE T1 5 mm
Coronal  FLAIR 5mm
Coronal High Resolution T2 perpendicular to the 
hippocampus
Axial DWI min b=1000
Post contrast Axial T1 and FLAIR coronal
For the paediatric age group add:
T1 GRE volume.  Primary acquisition in the coronal plain.
T1 IR Axial or coronal
For focal seizures or secondary generalization add
SWI Axial
eople (9)
Show details
Laboratory tests
1. Measurement of serum prolactin is not 
recommended for the diagnosis of epilepsy. 
2. In adults, appropriate blood tests (for example, 
plasma electrolytes, glucose, calcium) to 
identify potential causes and/or to identify any significant 
co-morbidity should be considered.  
3. In children and young people, other investigations, 
including blood and urine biochem 
should be undertaken at the discretion of the specialist to 
exclude other diagnoses, and to 
determine an underlying cause of the epilepsy.  
4. B12, vitamin D and serum iron, Mg, Ca, LFTs and 
serum creatine kinase, complete blood count, creatinine 
should be checked especially when on AED’s. 
Cardiovascular tests as an aid to diagnosis 
 1.  A 12-lead ECG should be performed in adults over age 
30 with suspected epilepsy. 
2.  In children and young people, a 12-lead ECG should 
be considered in cases of diagnostic 
uncertainty. 
3. In cases of atypical attacks and strong possibility 0f 
syncope or any arrhythmia on EKG,  a referral to a 
cardiologist should be considered. 
 
The role of neuropsychological assessment in the 
diagnosis and management of epilepsy? 
Neuropsychological deficits are commonly associated with 
epilepsy and its treatment.  Awarenes of these problems 
may facilitate education, social integration and 
employment
1. Neuropsychological assessment should be 
considered in children, young people and adultin whom it 
is important to evaluate learning disabilities and cognitive 
dysfunction,
 particularly in regard to language and memory. 
2. when a child, young person or adult  with epilepsy is 
having educational or occupational 
difficulties 
3. when an MRI has identified abnormalities in 
cognitively important brain regions 
4. when a child, young person or adult complains of 
memory or other cognitive deficits and/or cognitive 
decline. 
 
Conclusion
The primary scope of these guidelines is to provide a 
concise practical plan which will help identify the seizure, 
and classify it in the simplest possible form. These 
guidelines hope to provide the physicians treating epilepsy 
patients with a step wise approach to the diagnosis 
patient with epilepsy. Though some of these diagnostic 
tests are expensive making the correct diagnosis at an 
initial stage of the disease can same much in long term 
cost of morbidity and polypharmacy.
A health care structure needs to be created on the 
governmental level to provide subsidized AEDs and 
diagnostic facilities.
These guidelines will be revisited and modified on 
applicability every four years. People with epilepsy remain 
at the centre of this guideline, and the need for services 
to consider the needs of each individual and their care 
givers have been focused. 
Appendix B
EPILEPSY IN CHILDREN AND NEONATES
Diagnosis: 
Making the correct diagnosis is extremely important in 
children due to long term implications like educational, 
psychosocial, intelligence quotient, development, self 
esteem and the psychological impact on their parents. 
Misdiagnosis is more common in peads than in adults, 
particularly when diagnosis is made by non specialists. 
Recognizing and classifying seizures is different in 
neonates , infants and children as does the etiology and 
management.
 
Classification:  
See Appendix A
Treatment: 
The basic principles of AED treatment in children with 
epilepsy (CWE) remain the same as in adults. CWE should 
be encouraged to participate in normal activities with their 
peers , supervised where needed depending on the type 
of activity and seizure history. Parents of CWE should be 
advised not to be over protective. 
NEONATAL SEIZURES
Diagnosis of neonatal seizures is essentially clinical and 
must be based on observation of repeated or rhithmic 
activity which is (subtle) for example orofacial twitching, 
(clonic) limb movements, jerking not stopped when held,  
autonomic disturbances, stiffening (tonic) or sustained 
posturing of limbs. Home video of events is helpful in 
diagnosis and further management of such neonates 
needs to be done under specialized care. 
Table 1: Causes of Neonatal seizures
Ideal Metabolic Evaluation should include:
•  Blood:  glucose, lytes, BUN, creatinine, lactate, 
pyruvate, ammonia, biotinidase, quantitative amino acids, 
very long chain fatty acids
• Urine:  quantitative amino acids
• CSF:  cell count, glucose, protein, pyruvate, lactate, 
quantitative amino acids, HSV PCR
Unfortunately these are very costly and some need to be 
sent abroad increasing cost.  
General Recommendations
• All neonates with seizures should be given pyridoxine 
50-100mg 
• Neonatal screening TSH, 
• lactic acid, if acidosis biotin should be given and 
acidosis corrected.
•  serum AA and urine organic acids if inborn errors 
suspected e.g. sibling history or consanguineous marriage.  
• Stabilize vital signs and  treat underlying hypotension
• Correct transient metabolic disturbances
• Phenobarbital is first line agent
• Lorazepam and Phenytoin second line 
• Valproate and Levitiracetam if myoclonic fits.
• See table for oral AEDs that can be used
• Refer to Pediatric Neurologist ASAP
Table 3. Oral AEDs that can be used in Neonatal seizures 
 
Acute Therapy of Neonatal seizures : 
If with hypoglycemia- Glucose 10%: 2ml/k IV
If no hypoglycemia- Phenobarbital:20mg/k IV
       loading dose
       If necessary : additional phenobarbital:
       5 mg/kg IV to a max of 20 mg/kg
       (omit if respiratory compromise)
        Phenytoin: 20 mg/kg, IV (1 mg/kg/min)
        Lorazepam:0.05-0.10 mg/kg, IV  
All neonates with intractable seizures should be given 
50-100mg iv pyridoxine.
FEBRILE SEIZURES or FITS (FF)
1. Fits that occur in otherwise normal infants from age 6 
months to 6years on during high fever greater than 101oF 
or 38oC. (fever not caused by meningeal or cerebral 
infection)
2. Single FF occurs in 3-5% of children. Recurrent FF 
occurs in one third of children with FF. Recurrance is 
higher if first FF within first year of life.
3. FF may be simple or complex and this helps 
prognosticate the FF. Simple is brief, generalized <1min. 
Complex FF comprise only 15% of FF, usually partial onset, 
longer >15 minutes or multiple fits in the same illness. 
These are more likely to develop epilepsy in the future. 
4. LP (lumbar puncture) should be done in children 
suspected of CNS infection 
5. Recurrent simple FF do not warrant investigation and 
need parental counseling 
6. EEG is not required in Simple FF. it should be done in 
complex FF, febrile status epilepticus. 
7. FF is never focal
8. Neuroimaging has no role in simple FF
9. FF counseling should include lowering body 
temperature, acutely acting antiepileptic drugs like 
diazepam  orClobazam 0.75mg/kg in two divided doses, 
or phenobarbitone prophylactically during fever only. 
10. Continued prophylaxix with AEDs is not recommended 
in FF. 
11. Parents need to be taught the use of rectal diazepma 
0.5mg/kg and/or buccal midazolam (0.2-0.3mg/kg) for 
acute termination of seizure if lasts longer than 2 minutes. 
12. Parents should be cautious not to let fever rise in 
such children
CHILDHOOD Specific EPILEPSY SYNDROMES: 
(pharmachologic management)
Pharmacological management of ABSENCE 
SEIZURES 
1. Ethosuximide or sodium valproate as firstline treatment 
to children, patients with
absence seizures. If there is a high risk of GTC seizures, 
offer sodium valproate first, 
unless it is unsuitable. Be aware of teratogenic risks of 
sodium valproate. NOTE: Ethosuximide is not available in 
Pakistan.
2. Lamotrigine if ethosuximide and sodium valproate are 
unsuitable, ineffective or not tolerated. 
3. If two firstline AEDs  are ineffective in patients with 
absence seizures, consider a combination of two of these 
three AEDs as adjunctive treatment: ethosuximide, 
lamotrigineor sodium valproate. Be aware of teratogenic 
risks of sodium valproate  
4. If adjunctive treatment is ineffective or not tolerated, 
discuss with, or refer to epilepsy specialist and consider 
clobazam, clonazepam, levetiracetam, topiramate,or 
zonisamide (not available in Pakistan)
5. Do not offer carbamazepine, gabapentin, oxcarbazepine, 
phenytoin, pregabalin, tiagabine or vigabatrin.
6. Avoid VPA with clonazepam in childhood absences it 
can induce absence status
Pharmacological management of myoclonic seizures 
1. Offer VPA as first-line treatment to children, with  newly 
diagnosed myoclonic seizures, 
unless it is unsuitable. 
2. Offer LEV or TPM if VPA is not suitable or patient not 
responding
(Be aware that TPM has a less favourable sideeffect 
profile than LEV and VPA) 
3. Offer LEV, VPA or TPM as adjunctive treatment to 
children, with myoclonic seizures if firstline treatments are 
ineffective or not tolerated. Be aware of teratogenic risk of 
VPA 
4. If adjunctive treatment  is ineffective or not tolerated, 
discuss with, or refer to, epilepsy specialist and consider 
clobazam,clonazepam, piracetam or zonisamide or 
steroids. 
5. Do not offer carbamazepine, gabapentin, oxcarbazepine, 
phenytoin, pregabalin, tiagabine or vigabatrin. 
 
Pharmacological management of INFANTILE SPASMS 
1. Discuss with, or refer to, a tertiary paediatric epilepsy 
specialist when an infant presents with infantile spasms. 
These children will need polytherapy.
2. Offer a steroid (prednisolone or tetracosactide or ACTH) 
or vigabatrin with VPA as first-line treatment to infants with 
infantile spasms that are not due to tuberous sclerosis. 
Carefully consider the risk-benefit  when using vigabatrin 
or steroids. 
3. Offer vigabatrin with VPA as first-line treatment to 
infants with infantile spasms due to tuberous sclerosis. If 
vigabatrin is ineffective, offer a steroid (prednisolone or 
tetracosactide Carefully consider the risk-benefit when 
using vigabatrin or steroids. 
Pharmacological management of Dravet syndrome 
1. Discuss with, or refer to, a tertiary paediatric epilepsy 
specialist when a child presents with suspected Dravet 
syndrome. 
2. Consider VPA or TPM as first-line treatment in children 
with Dravet syndrome. 
3.If first-line treatments in patients with Dravets syndrome 
are ineffective or not tolerated try clobazam or stiripentol 
(* not available in Pakistan) as adjunctive treatment. 
4. Do not offer CBZ, gabapentin, LTG, OXC, PHT, 
pregabalin, tiagabine or vigabatrin.  
Pharmacological management of LENNOX-GASTAUT 
SYNDROME 
1. Discuss with, or refer to, a tertiary paediatric/ epilepsy 
specialist when a child presents 
with suspected Lennox–Gastaut syndrome. Most require 
poly-therapy
2. Offer VPA as first-line treatment to children with 
Lennox–Gastaut syndrome.   
3. Offer LTG, TPM as adjunctive treatment if first-line 
treatment with VPA is ineffective or not 
tolerated.  
4. Other AEDs that may be considered by the tertiary 
epilepsy specialist are rufinamide and topiramate and 
polypharmacy with benzodiazepines, trial of steroids may 
also be considered. 
5. Do not offer CBZ, gabapentin, OXC, pregabalin, 
tiagabine or vigabatrin. 
Pharmacological management of BENIGN EPILEPSY 
WITH CENTROTEMPORAL 
SPIKES,(BECTS)
1. Discuss with the child, and their family whether AED 
treatment for benign epilepsy with 
Centro-temporal spikes, 
2. Offer LTG or CBZ* as first-line treatment.
3. Offer LEV, OXC*, or VPA(avoid in older girls) as 2nd line 
if above fail
(*Be aware that carbamazepine and oxcarbazepine may 
exacerbate or unmask continuous spike and wave during 
slow sleep, which may occur in some children with benign 
epilepsy with centrotemporal spikes. Be aware of 
teratogenic risks of VPA and rash with LTG.)
4. Consider adjunctive treatment if a second well-tolerated 
AED is ineffective. 
5. Offer clobazam, gabapentin, LTG, LEV, OXC, VPA, TPM, 
LCM if first-line treatments fails
Refractory childhood epilepsy syndromes adjuvant 
AEDs
Other AEDs that may be considered by the tertiary 
epilepsy specialist are eslicarbazepine 
acetate, pregabalin, tiagabine, vigabatrin, LCM, and 
zonisamide,PB, PHT, TPM,
Carefully consider the risk–benefit ratio when using 
vigabatrin due to irreversible visual field constriction in 
upto 30%  
Ketogenic diet, medical marijuana, methylprednisone, 
clobazam,  nitrazepam, clonazepam, lorazepam are also 
recommended in refractory cases. 
Note
• In children, the diagnosis and management of 
epilepsy within the first few years of life may be extremely 
challenging.  For this reason, children with suspected 
epilepsy should be referred to tertiary services early, 
because of the profound developmental, behavioural and 
psychological effects that may be associated with 
continuing seizures.  
• Behavioural or developmental regression or inability 
to identify the epilepsy syndrome requires immediate 
referral to tertiary services. 
• Children, young people and adults with specific 
syndromes such as Sturge–Weber syndrome, the 
hemispheric syndromes, Rasmussen’s encephalitis and 
hypothalamic hamartoma should be referred to a tertiary 
epilepsy service.  
• All PWE and learning disabilities should have a risk 
assessment including: 
• bathing and showering 
• preparing food 
• using electrical equipment 
• managing prolonged or serial seizures 
• the impact of epilepsy in social settings 
• SUDEP 
Annexure: RCT review and our modifications)
Partial Seizures: Children
Recommendations 
Level A: OXC
Level B: None (RTC) LTG (NICE)
Level C: CBZ, PB, PHT,TPM, VPA, VGB
Level D: LTG, ZNS, CLB, CZP
Level E: Others
Level F: None
Recomendations: PB*, VPA, CBZ, OXC, LTG, 
Generalized Tonic Clonic Seizures: Children
Recommendations
Level A: None
Level B: None
Level C: CBZ*,PB, PHT*,TPM,VPA
Level D: OXC* LEV, LTG, (considered first line NICE)
Level E: Others
Level F: None
*may aggravate tonic clonic seizures and more commonly 
other generalized seizure types, should be used with 
caution 
Women of childbearing age with epilepsy 
Introduction 
Most women with epilepsy who are receiving optimal 
treatment for their epilepsy, and who are well-informed, 
supported and fully counselled have uncomplicated 
pregnancies, normal deliveries, and healthy children. 
However in Pakistan no such proper program or 
counseling or management plan is available. Thus number 
of complications and perinatal problems are high in WWE 
(women with epilepsy). A number of issues need to be 
considered 
• Both the disease and its treatment may alter the 
menstrual cycle and fertility.  
• There are problems with drug interactions, particularly 
with hormonal contraceptives.  Some methods of 
hormonal contraception may not be as effective in women 
taking AEDS.  The effectiveness will depend on which 
AED(s) are being taken. Effective contraception has an 
additional importance in women with epilepsy because of 
the risks associated with an unplanned pregnancy to the 
women and the developing  fetus.  
• AEDs are associated with teratogenic effects.  
• Both AEDs and uncontrolled seizures can cause 
adverse effects during pregnancy.  
Conversely, pregnancy and menses can affect seizure 
control due to hormonally induced alteration of the seizure 
threshold.
• Every pregnancy is different. 
Management of Epilepsy in Women can be divided into 5 
phases: 
1. COUNSELLING
2. CONTRACEPTION
3. PREGNANCY
4. LABOUR
5. POST PARTUM AND LACTATION 
COUNSELLING 
• In order to enable informed decisions and choice, and 
to reduce misunderstandings, women  and girls with 
epilepsy and their partners, as appropriate, must be given 
accurate information and counselling about contraception, 
conception, pregnancy, caring for children and 
breastfeeding, and menopause.  
• All healthcare professionals who treat, care for, or 
support women and girls with epilepsy should be familiar 
with relevant information and the availability of counseling 
the risk of AEDs causing malformations and possible 
neurodevelopmental impairments in an unborn child.
• Assess the risks and benefits of treatment with 
individual drugs. There are limited data on risks to the 
unborn child associated with newer drugs. Specifically 
discuss the risk of continued use of sodium valproate to 
the unbornchild, being aware that higher doses of sodium 
valproate (more than 800 mg/day) and polytherapy, 
particularly with sodium valproate, are associated with 
greater risk. (see table drugs and teratogenicity)
CONTRACEPTION
1. CBZ, PHT, OXC, TPM and barbiturates reduce the 
effectiveness of oral contraceptives
 necessitating the use of alternative methods, or special 
highdose regimens of oral contraceptives.  Even with this 
precaution, the effectiveness of the oral contraceptive is 
reduced.  (Ia NICE) 
2. Hormone-releasing IUDs are effective as a method of 
contraception in women taking AEDs. 
3. There is limited evidence that progesterone implants 
(specifically levonorgestrel) are ineffective
 in women taking enzyme-inducing AEDs. 
4. Progesterone pill should be avoided. 
5. There is no evidence on the effectiveness of emergency 
contraception in women taking enzyme-
inducing AEDs. 
6. There needs to be a National Pregnancy registry.
PREGNANCY
7. AED’s should be continued in pregnancy. There is no 
benefit of stopping AED’s after 3-4 weeks of conception 
(nural tube formed), and risk of seizures outweighs risk of 
continued AED exposure in vitro. 
Table 12: AED’s and Pregnancy Risk: 
8. When should screening for structural fetal anomalies 
be performed in pregnant women 
with epilepsy? 
A recent NICE guideline reviewed the evidence on the 
detection of structural fetal abnormalities in healthy 
pregnant women.
It is recommended that ‘pregnant women should be 
offered an ultrasound scan to screen for structural 
anomalies, ideally between 18 to 20 weeks of gestation, 
by an appropriately trained sonographer and with  
equipment of an appropriate standard.
9. When should folic acid be started? 
• All women nd girls on AEDs should be offered 5mg
per day of folic acid before any possibility of pregnancy.  
• There is limited evidence to show that folic acid 
supplementation reduces the risk of
• Neural tube defects and other congenital 
malformations in women taking AEDs.   
• Women who are planning pregnancy should be 
advised to take 400mcg of folic acid from when they 
begin trying to conceive until the 12th week of pregnancy 
and that those who suspect they are pregnant and who 
have not been taking supplements should start folic acid 
supplements 5mg immediately and continue until the 
12th week of pregnancy.
10. Serum levels of AEDs are of help during pregnancy. 
The dose of AEDs should not be increased routinely if 
levels are low except if seizures start occurring, and at the 
time of delivery to avoid breakthrough seizures during the 
stress of labour. 
11. If preterm labor is threatened in women taking 
enzyme-inducing AEDs, 48mg betamethasone (double 
the normal dose) should be given over 48 hours. 
12. Vitamin K 10mg i.m. at 34 and 36 weeks is 
recommended for all women unless there is a 
contraindication. 
13. Some counseling points: 
What are the dangers of seizures in women who are 
pregnant or post-natal? 
• Women and girls with epilepsy need accurate 
information during pregnancy, and the possibility of status 
epilepticus and SUDEP should be discussed with all 
women and girls who plan to stop AED therapy 
• Women and girls with generalised tonicclonic seizures 
should be informed that the fetus may be at relatively 
higher risk of harm during a seizure, although the absolute 
risk remains very low, and the level of risk may depend on 
seizure frequency. 
• There is no evidence that simple focal, complex focal, 
absence and myoclonic seizures adversely affect the 
pregnancy or developing fetus.  
• Generalized tonicclonic seizures are likely to result in 
more profound hypoxia than in the nongravid state due to 
increased maternal oxygen requirements.  This may have 
adverse affects for the fetus
POST-CONCEPTION
14. Counselling about safety during child rearing, like to 
keep baby in a crib next to the bed, care to avoid dropping 
the baby especially JME.
15. Breast Feeding guide: All mothers should be 
encouraged to breast feed. 
16. The doseage of AEDs such as LTG, LEV, OXC may have 
to be reduced if they were raised during pregnancy but 
after 6 weeks post partum 
17. Spacing between pregnancies should be 
recommended and safe/ effective contraceptive methods 
should be offered to all WWE. 
MANAGEMENT OF STATUS EPILEPTICUS Guidelines 
for Pakistan:
When a convulsive seizure continues for a prolonged 
period (longer than 5 minutes), or when convulsive 
seizures occur one after the other with no recovery in 
between patient is considered to be in Status Epilepticus. 
Convulsive status epilepticus is an emergency and 
requires immediate medical attention. TREAT HARD and 
TREAT FAST 
APPENDIX : STATUS EPILEPTICUS PROTOCOL
Definition:  
1. Convulsive Status Epilepticus (CSE): in adults and 
children older than 5 years is characterized by continuous 
convulsive seizures lasting more than 5 minutes or two or 
more seizures in 20 minutes without gaining 
consciousness in between.
2. Non-convulsive status epilepticus (NCSE) is mental 
status changes from baseline for at least 30 minutes 
associated with ictal discharges on EEG. It should be 
suspected in patient after convulsive seizure who is not 
regaining consciousness. 
3. Refractory Status Epilepticus: (RSE) Seizure activity 
that continues after first and second line AED therapy 
have failed. This can be CSE and NCSE.
MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS:
PRE-HOSPITAL STAGE: FIRST 5-10 MINUTES
• Children: Rectal diazepam 0.5mg /kg or buccal 
midazolam 0.2-0.3mg/kg ; adults: rectal diazepam 10mg 
or buccal midazolam 10mg (home)
• Maintain iv line as soon as possible and administer 
5-10mg diazepam or 3-5 mg midazolam iv push followed 
by saline flush. (EMS)
• Secure airway, breathing and circulation
HOSPITAL STAGE: 5-20 MINUTES
• Diazepam 0.2mg /kg (maximum 10mg) over 
1minute,OR midazolam 0.2mg/kg ivp or im, upto 10mg;  
wait 5 minutes for seizures to terminate. Order and 
prepare IV phenytoin. If seizure terminates investigate 
cause of seizures further, if not repeat again .in children 
<2years give neurobioniv to replace thiamine and biotin. 
• Give Oxygen, stabilize airway, respitation and 
hemdynamic parameters, apply pulse oxymetry.
• Send RBS, LFT, renal functions, electrolytes, BUN, and 
CT scan. LP and CSF analysis if CNS infection suspected.
• Start PHT infusion 15-20mg/kg at maximum rate of 
50mg/min (1mg/kg/min in small children) AVOID dilution in 
glucose solution. Monitor heart rate and blood pressure, 
contraindicated in patients with heart block or hypotention 
SBP<95. (phosphenytoin 15-18mg PE/kg/min at max rate 
of 150mg PE/min is internationally the drug of choice but 
unfortunately not available in Pakistan)
HOSPITAL STAGE : ESTABLISHED GSCE 20-60minutes: 
• If seizures continue 5-10 mins after PHT, reload 
5-10mg/kg iv at same rates as above
• Seizures continue give Sodium Valproate 
25-35mg/kg at a rate of 6mg/kg/hr
• Arrange for intubation, anaesthesia on board
• Seizures continue give iv levitiracetam  loading 
1000-3000mg (adults) at 2-5mg/kg/min
• Seizures continue next stage RCE.
• Start phenobarbitone50-100mg/min IV loading dose, 
and if intubated can start infusion 0.5-5mg/kg/hr or skip 
to next stage RCE
HOSPITAL STAGE: Refractory Status Epilepticus 
(more than 60 mins)
• Prepare to intubate and transfer to ICU
• Start lacosamide 200-400mg IV 200 mg over 15 
mins (adults only)
• Ideally obtain central venous access and contiuous 
hemodynamic monitoring through arterial line and EEG 
monitoring
• Anaesthetic agents: Adults and children midazolam 
0.2mg/kg IV bolus followed by 0.1-0.4mg/kg/hour 
continuous iv infusion OR propofol 2-5mg/kg IV bolus 
followed by 5-10mg/kg/hr iv infusion OR thiopental 
10-20mg/kg IV bolus followed by 0.5-1mg/kg/hr IV infusion 
till EEG shows burst suppression (pharmacologic coma)
• Continue coma phase  for 12 hours after last seizure
• Weaning phase: reduce infusion of anaesthetic agent 
every 3 hours with EEG monitoring, if seizures recur 
re-institute coma with the same anaesthetic to the dose 
where seizures were responsive. 
• Add topiramate 200 mg bolus and 100 mg tid. 
• Identify and treat medical complications correct 
acidosis if pH 7.2 or if symptomatic in the form of cardiac 
disturbances. Vigorously treat infections, avoid penicillin 
and quinolone group of antibiotics. 
• If seizures continue and autoimmune or idiosyncratic 
modulation is suspected consider puse steroids and ivIG. 
POST STATUS PHASE
• Maintenance therapy, all AEDs that were used to 
treat the status should be continued on maintainance 
dosage till patient remains seizure free for at least 3-7 
days if patient awake, if GCS remains low gradually 
remove under EEG coverage.
